hg_184180.1

Basic information about the TSS

---

TSS ID: hg_184180.1 Species: human Chr: chr20		Start: 33811231 End: 33811242 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000217402.2 NM_176812 uc002xaa.4 Distance: 62 GeneID: 128866 HGNC/MGI_ID: HGNC:16171 UniProt_ID: Q9H444

Gene_name: charged multivesicular body protein 4B Gene_symbol: CHMP4B Gene_synonyms: SNF7-2 Shax1 VPS32B dJ553F4.4 Gene_source: HGNC:16171

TATA-Box annotation

---

Distance to TSS:	-67
Nearest PromoterID:	NM_176812
Entrez ID:	128866
Nearest Unigene:	Hs.472471
Nearest Refseq:	NM_176812
Nearest Ensembl:	ENSG00000101421
Gene Name:	charged multivesicular body protein 4B
Gene Alias:	C20orf178
Gene Description:	charged multivesicular body protein 4B
Gene Type:	protein-coding
CpG%:	0.115
GC%:	0.711443
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CHMP4B p2@CHMP4B p3@CHMP4B p4@CHMP4B p5@CHMP4B p6@CHMP4B
Sample		p1@CHMP4B	p2@CHMP4B	p3@CHMP4B	p4@CHMP4B	p5@CHMP4B	p6@CHMP4B
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	36.04	7.60	0.78	1.36	0.39	4.29
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	37.02	10.12	1.62	1.01	0.61	5.87
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	33.76	7.91	0.58	1.93	0.77	5.79
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	32.43	8.32	0.62	0.83	0.83	4.37
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	44.54	9.67	2.47	1.12	0.45	5.17
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	33.92	8.33	2.13	1.36	0.00	3.68
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	48.81	13.51	3.27	1.31	0.44	7.19
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	38.03	13.32	1.94	1.70	0.48	8.96
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	48.51	11.54	2.14	1.28	0.85	6.63
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	43.47	5.22	1.74	2.32	0.00	4.64
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	37.19	8.89	3.23	2.43	0.40	10.91
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	41.87	11.38	2.03	2.44	0.41	5.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	37.72	5.80	0.81	0.16	0.32	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	34.88	5.11	0.90	0.15	0.60	1.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	32.93	5.05	0.00	0.22	0.22	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	30.18	3.52	1.51	0.00	0.25	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	24.02	3.71	1.31	0.00	0.87	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	19.83	3.37	0.84	0.00	0.00	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	22.39	3.20	0.53	0.53	0.53	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	40.92	4.51	1.20	0.15	0.45	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	36.62	6.82	0.80	0.27	0.53	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	42.98	6.39	1.21	0.35	0.69	2.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	34.90	5.56	1.29	0.26	0.26	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	35.91	3.88	1.46	0.49	0.97	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	30.70	4.39	0.26	0.77	1.03	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	40.51	6.33	0.63	0.00	0.95	2.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	28.57	2.75	0.55	0.55	0.55	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	55.17	8.72	0.94	0.47	0.47	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	41.19	7.11	1.78	0.00	0.48	2.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	53.02	7.06	1.99	0.18	0.18	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	43.54	9.00	1.88	0.00	1.26	2.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	31.85	6.64	0.78	0.59	0.59	1.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	39.04	6.33	1.27	0.42	0.42	2.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	47.67	8.91	2.31	0.82	0.49	2.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	45.81	8.04	1.12	0.19	1.12	3.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	50.40	6.71	0.96	0.00	0.96	2.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	55.59	9.40	2.25	0.41	1.23	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	44.93	8.06	1.81	0.60	0.60	3.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	54.83	9.18	2.43	0.81	0.00	4.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	65.06	8.40	1.44	0.24	0.24	2.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	55.76	9.18	2.35	0.47	0.47	3.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	49.19	10.83	1.46	0.00	0.15	2.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	54.41	9.07	2.53	0.42	1.69	3.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	54.72	9.44	2.80	0.35	0.35	3.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	65.85	8.83	1.81	0.20	0.40	3.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	63.28	9.31	2.33	0.23	0.93	2.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	46.78	8.40	2.16	0.48	0.48	3.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	58.12	7.75	2.68	0.30	0.89	2.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	53.62	6.22	1.91	0.24	0.48	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	57.22	8.49	2.63	0.40	0.61	2.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	55.95	8.81	1.23	0.20	1.02	1.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	60.71	10.45	2.89	0.67	0.67	4.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	209.88	41.98	13.99	0.00	13.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	45.07	7.45	2.48	0.35	1.06	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	53.68	5.30	0.99	0.66	0.66	1.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	104.87	9.23	0.84	1.68	3.36	7.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	87.72	5.51	1.38	0.46	2.30	4.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	32.09	7.13	1.94	0.32	1.62	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	28.58	7.39	1.28	0.32	0.64	1.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	86.13	8.49	1.89	0.31	1.57	7.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	38.07	7.05	0.71	0.71	0.71	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	45.98	5.61	1.68	0.00	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	83.59	3.18	2.39	0.00	3.18	4.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	72.37	4.42	1.36	0.68	1.02	2.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	32.49	4.22	0.97	0.00	0.97	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	35.85	3.55	1.06	0.00	1.06	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	177.80	16.16	16.16	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	284.31	23.69	0.00	7.90	0.00	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	37.54	1.46	1.46	0.49	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	40.66	1.49	1.49	0.00	0.50	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	42.22	5.16	0.47	0.94	0.47	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	59.95	3.64	2.32	0.33	0.33	1.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	32.17	2.17	1.24	0.00	0.62	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	29.66	2.14	2.14	0.31	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	47.99	3.64	0.79	0.16	0.63	1.58
Adipocyte - breast, donor2	11327-117E4	52.62	2.41	0.96	0.48	1.60	1.12
Adipocyte - omental, donor1	11473-119C6	46.82	2.42	1.27	0.13	0.38	1.53
Adipocyte - omental, donor2	11474-119C7	78.49	2.99	0.00	0.75	0.75	2.99
Adipocyte - omental, donor3	11475-119C8	56.60	3.35	1.34	0.67	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	58.70	3.19	1.91	1.28	0.64	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	35.18	0.00	1.10	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	62.32	1.35	0.45	0.00	0.00	1.35
Adipocyte - subcutaneous, donor3	11408-118E4	46.40	3.82	1.39	0.17	0.35	0.87
Adipocyte differentiation, day04, donor1	13019-139D4	112.06	4.11	1.37	0.98	0.20	1.37
Adipocyte differentiation, day04, donor2	13022-139D7	63.32	2.32	0.26	0.77	0.51	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	63.84	2.79	0.56	1.95	0.56	1.39
Adipocyte differentiation, day04, donor4	13028-139E4	62.31	3.53	1.76	0.00	0.59	1.76
Adipocyte differentiation, day08, donor1	13020-139D5	85.26	5.39	1.37	0.64	0.88	1.29
Adipocyte differentiation, day08, donor2	13023-139D8	59.71	2.58	0.65	0.65	0.32	1.61
Adipocyte differentiation, day08, donor3	13026-139E2	46.92	3.73	1.60	0.53	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	30.60	2.23	1.11	0.56	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	43.25	2.50	0.42	0.00	0.00	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	47.72	2.51	0.50	0.75	0.00	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	37.96	2.62	0.33	0.00	0.00	1.31
Adipocyte differentiation, day12, donor4	13030-139E6	42.02	3.96	0.30	0.00	0.30	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	101.88	3.76	1.99	0.66	0.22	0.88
Alveolar Epithelial Cells, donor2	11590-120G6	102.55	2.15	1.43	2.15	0.72	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	40.73	3.59	2.40	0.00	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	114.96	10.79	2.16	1.44	1.08	2.88
Amniotic Epithelial Cells, donor2	11613-122A2	83.67	6.69	0.00	1.67	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	88.75	7.40	2.88	0.62	1.03	1.23
Anulus Pulposus Cell, donor1	11248-116E6	50.23	6.98	1.26	0.00	0.23	2.29
Anulus Pulposus Cell, donor2	11463-119B5	56.33	10.53	0.73	0.24	1.47	2.20
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	49.87	0.45	1.35	0.45	0.45	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	56.44	5.21	1.30	0.43	0.00	2.17
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	36.38	0.00	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	67.86	5.08	1.79	1.49	0.90	1.20
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	65.76	3.79	0.00	0.00	1.26	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	31.02	2.64	1.32	1.32	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	52.96	4.22	0.65	1.30	0.97	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	63.11	5.34	0.00	0.97	0.49	1.94
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	27.32	5.94	0.00	0.59	0.59	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	55.37	4.14	0.75	1.13	1.51	1.88
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	53.70	1.45	1.45	1.45	0.73	3.63
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	28.84	1.25	0.00	0.00	1.25	3.76
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	46.79	3.29	1.32	1.15	0.49	1.15
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	51.86	10.92	2.73	2.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	38.00	2.71	0.75	0.90	0.45	1.21
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	50.90	2.68	1.07	1.07	2.14	1.61
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	61.97	4.91	0.76	1.32	1.51	2.83
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	41.43	2.67	1.60	0.00	0.53	2.67
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	52.67	1.95	0.98	1.95	0.98	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	64.52	6.80	1.33	1.33	1.00	2.82
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	32.42	6.00	3.60	1.20	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	49.56	7.08	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	74.27	6.00	1.20	0.69	0.17	1.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	12.58	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	53.88	3.40	0.97	1.46	0.97	1.94
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	74.75	4.17	1.14	0.00	0.38	3.04
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	43.61	3.63	0.00	1.21	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	54.15	4.56	1.71	0.57	0.57	3.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	62.85	5.77	0.64	0.43	0.86	2.35
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	33.55	4.90	1.81	0.26	0.77	1.03
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	50.67	4.22	0.47	1.88	0.47	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	61.09	5.47	1.93	0.64	0.00	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	35.67	2.85	0.00	1.43	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	50.31	4.09	1.75	0.58	0.58	1.75
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	50.88	4.52	1.20	0.60	0.00	1.20
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	39.20	1.19	1.19	1.19	0.00	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	60.01	4.58	1.02	1.53	0.00	3.56
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	67.49	3.57	0.76	0.76	1.78	1.78
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	35.58	2.54	1.91	0.64	0.00	1.91
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	52.65	7.77	1.29	1.29	0.86	1.73
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	65.20	5.08	1.69	0.42	0.64	2.33
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	37.12	4.06	0.58	0.29	0.29	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	51.96	3.78	0.94	0.94	1.89	2.83
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	64.59	4.75	1.53	1.53	0.34	1.86
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	25.48	2.32	2.32	4.63	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	63.38	4.23	0.00	0.00	2.11	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	67.54	4.29	1.72	1.07	0.21	2.14
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	33.09	4.21	0.00	1.20	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	55.40	8.02	0.00	0.00	0.73	2.19
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	73.10	5.75	1.84	1.15	0.23	2.07
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	33.15	5.10	0.00	2.55	2.55	5.10
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	42.20	3.31	0.76	1.02	0.25	1.02
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	73.70	6.81	1.86	2.48	0.41	1.03
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	35.19	4.59	1.53	0.92	0.92	2.45
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	59.75	8.13	3.35	0.48	0.48	3.35
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	67.19	5.32	1.11	0.89	1.55	2.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	42.72	4.58	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	51.51	6.65	1.11	0.55	1.66	3.32
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	59.05	6.09	1.59	0.53	1.06	2.38
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	32.35	4.36	1.45	0.36	1.09	0.73
Astrocyte - cerebellum, donor1	11500-119F6	85.60	4.67	0.86	0.86	0.12	2.58
Astrocyte - cerebellum, donor2	11580-120F5	76.85	6.33	0.68	0.68	0.86	2.05
Astrocyte - cerebellum, donor3	11661-122F5	55.16	4.19	0.21	0.00	0.21	1.05
Astrocyte - cerebral cortex, donor1	11235-116D2	73.20	7.67	2.09	0.70	0.35	2.09
Astrocyte - cerebral cortex, donor2	11316-117D2	71.99	7.60	1.13	1.62	1.78	1.78
Astrocyte - cerebral cortex, donor3	11392-118C6	82.63	8.50	1.64	1.04	1.04	1.64
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	104.71	9.86	1.95	1.38	0.92	2.18
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	106.11	12.65	2.00	2.51	0.75	2.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	92.63	9.67	1.02	1.25	0.57	1.93
Basophils, donor1	12241-129G9	196.41	2.62	0.78	1.31	1.31	0.78
Basophils, donor2	12242-129H1	176.43	5.77	2.89	2.89	2.16	1.44
Basophils, donor3	12243-129H2	237.99	7.94	3.09	1.47	0.59	2.20
Bronchial Epithelial Cell, donor1	11511-119G8	58.86	7.55	2.16	0.00	0.22	1.72
Bronchial Epithelial Cell, donor2	11591-120G7	59.43	1.83	0.00	0.00	0.00	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	35.87	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	45.82	1.88	0.63	0.00	0.63	1.88
Bronchial Epithelial Cell, donor5	11457-119A8	48.87	4.78	0.83	0.00	0.42	0.83
Bronchial Epithelial Cell, donor6	11461-119B3	33.85	2.30	0.23	0.00	0.23	0.92
Bronchial Epithelial Cell, donor7	11769-123I5	39.59	2.70	1.08	0.18	0.18	0.54
Burkitt's lymphoma cell line:DAUDI	10422-106C8	51.53	2.16	0.62	0.41	0.21	0.72
Burkitt's lymphoma cell line:RAJI	10476-106I8	78.72	8.62	1.63	0.47	0.93	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	51.48	5.12	0.32	0.64	1.28	1.60
CD133+ stem cells - cord blood derived, pool1	12223-129E9	103.42	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	440.14	9.58	7.33	2.82	0.56	3.38
CD14+ Monocytes, donor2	11305-117B9	371.39	8.35	7.80	5.01	4.83	1.67
CD14+ Monocytes, donor3	11381-118B4	306.03	7.24	3.95	2.85	2.20	1.54
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	98.22	1.70	0.57	0.85	0.57	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	105.38	0.76	0.00	1.14	0.76	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	126.57	4.60	1.64	0.99	0.33	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	168.69	5.93	1.73	6.36	3.90	2.46
CD14+ monocytes - mock treated, donor2	11873-125C1	179.84	4.22	1.81	3.02	1.21	2.11
CD14+ monocytes - mock treated, donor3	11883-125D2	202.31	7.58	2.37	3.79	1.66	3.32
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	164.22	3.85	2.34	10.04	2.18	1.51
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	191.55	2.48	1.93	8.83	3.59	1.66
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	272.47	5.21	2.73	13.64	1.24	3.47
CD14+ monocytes - treated with BCG, donor1	11860-125A6	150.37	3.33	1.57	7.83	1.17	1.37
CD14+ monocytes - treated with BCG, donor2	11870-125B7	152.41	4.45	1.60	7.48	2.67	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	221.33	5.01	1.74	6.96	0.44	1.52
CD14+ monocytes - treated with Candida, donor1	11868-125B5	217.97	7.26	6.09	25.05	1.87	1.40
CD14+ monocytes - treated with Candida, donor2	11878-125C6	291.47	6.86	3.70	26.93	2.64	2.11
CD14+ monocytes - treated with Candida, donor3	11888-125D7	301.75	9.98	5.55	35.50	1.11	5.55
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	175.82	4.76	1.93	6.84	4.31	1.64
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	180.59	4.79	3.39	5.79	2.39	2.39
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	229.23	3.96	3.75	8.54	1.25	2.71
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	284.38	5.26	4.58	21.05	3.66	2.06
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	276.65	5.66	4.07	16.51	1.58	1.81
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	315.56	3.49	6.55	22.26	4.36	2.62
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	119.16	2.69	1.88	3.77	1.08	1.34
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	166.44	5.06	1.40	2.79	1.92	1.57
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	202.84	5.89	0.42	5.47	1.68	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	343.17	7.72	9.00	27.56	5.33	2.57
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	441.04	8.10	7.05	25.01	5.28	1.41
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	522.52	6.14	10.97	30.71	4.39	2.63
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	125.90	3.31	2.09	12.21	1.74	1.05
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	148.67	4.09	1.49	11.52	2.60	1.12
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	210.38	3.45	3.02	8.84	1.72	2.59
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	256.75	13.10	6.96	20.88	1.23	2.46
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	356.51	4.40	4.40	24.34	1.39	2.09
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	399.49	5.57	5.80	22.50	2.09	2.78
CD14+CD16+ Monocytes, donor1	11789-124B7	105.06	1.96	0.44	1.09	0.87	0.65
CD14+CD16+ Monocytes, donor2	11801-124D1	106.49	1.39	1.85	0.23	1.39	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	116.32	1.52	0.43	0.65	1.30	0.65
CD14+CD16- Monocytes, donor1	11788-124B6	109.47	1.87	1.40	0.62	1.09	0.93
CD14+CD16- Monocytes, donor2	11799-124C8	100.60	0.87	0.52	1.40	0.35	1.05
CD14+CD16- Monocytes, donor3	11910-125G2	196.44	2.90	0.45	1.11	0.45	1.34
CD14-CD16+ Monocytes, donor1	11790-124B8	134.22	1.28	0.77	0.77	1.02	0.77
CD14-CD16+ Monocytes, donor2	11800-124C9	101.88	0.44	0.44	1.10	0.88	0.66
CD14-CD16+ Monocytes, donor3	11911-125G3	153.28	2.53	0.84	0.84	1.05	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	136.16	6.10	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	107.12	0.68	0.00	0.68	2.71	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	90.10	1.04	0.00	0.00	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	98.08	1.60	0.00	1.60	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	125.44	1.07	1.07	2.68	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	103.89	1.40	0.70	0.70	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	98.83	2.35	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	119.96	2.64	0.00	0.00	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	59.18	2.47	0.82	0.00	1.64	0.82
CD19+ B Cells, donor2	11624-122B4	63.11	0.73	0.73	0.00	0.73	0.73
CD19+ B Cells, donor3	11705-123B4	70.17	0.00	0.00	0.50	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	143.84	15.35	6.46	0.40	0.40	1.62
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	99.07	10.39	4.39	0.80	0.00	2.40
CD34+ Progenitors, donor1	11545-120B6	24.10	5.02	1.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	188.77	7.87	2.81	1.69	0.00	3.93
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	48.85	4.51	0.00	1.50	0.38	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	57.50	4.06	1.35	0.45	0.00	1.13
CD4+ T Cells, donor1	11225-116C1	71.77	6.07	2.14	1.43	0.00	1.43
CD4+ T Cells, donor2	11306-117C1	71.03	6.74	0.00	0.00	1.84	3.06
CD4+ T Cells, donor3	11382-118B5	72.59	3.96	0.91	0.00	0.61	1.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	75.81	4.34	1.28	0.00	0.51	3.06
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	70.30	4.94	1.35	0.90	0.00	1.12
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	74.45	4.89	0.86	0.29	0.00	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	45.04	1.42	0.00	0.47	0.00	0.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	43.54	0.70	0.00	0.70	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	36.26	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	59.68	7.23	1.30	0.14	0.43	1.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	70.16	9.66	3.22	0.68	0.85	1.19
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	59.48	5.80	1.77	0.00	0.81	0.81
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	43.93	1.34	0.45	0.90	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	34.94	1.40	0.00	0.35	1.05	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	57.20	2.20	0.88	0.44	0.88	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	78.85	10.54	1.69	0.00	1.69	3.79
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	77.91	7.48	2.70	0.00	1.25	1.66
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	72.84	6.35	3.01	1.00	1.00	2.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	36.44	1.90	0.27	0.82	0.82	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	57.88	2.14	0.54	0.00	0.00	1.61
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	55.59	7.17	0.00	0.00	3.59	3.59
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	104.95	15.76	2.60	1.11	0.74	4.82
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	86.65	7.36	1.73	0.65	0.43	2.38
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	96.04	6.51	2.73	0.84	0.63	2.10
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	57.64	2.02	0.00	0.00	0.51	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	57.62	1.73	0.00	0.00	1.30	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	65.37	2.61	0.00	1.31	0.44	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	80.17	1.48	0.00	2.47	0.99	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	72.93	0.00	0.92	0.92	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	62.81	2.79	0.00	2.79	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	91.39	1.94	0.00	2.22	0.83	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	93.98	0.49	0.74	2.21	0.25	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	56.98	0.00	1.54	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	87.38	1.79	1.07	1.43	0.00	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	85.87	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	78.25	0.65	0.00	0.33	0.33	0.98
CD8+ T Cells, donor2	11307-117C2	82.97	5.26	1.50	1.88	1.13	3.00
CD8+ T Cells, donor3	11383-118B6	82.56	3.53	0.00	0.50	0.50	1.01
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	25.46	1.84	0.69	0.69	0.23	1.61
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	26.12	1.68	0.00	1.44	0.72	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	23.26	1.64	0.55	1.64	0.55	0.82
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	25.52	1.80	0.60	0.60	0.30	2.10
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	31.92	1.20	0.24	1.92	0.24	1.44
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	36.38	1.82	0.00	2.27	0.23	1.14
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	34.33	3.26	0.43	1.30	0.43	0.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	26.32	3.42	0.00	0.53	0.00	1.32
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	30.02	3.75	0.47	1.88	0.23	1.41
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	34.41	4.53	0.60	1.81	0.60	2.11
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	20.63	3.20	0.58	1.74	0.29	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	34.37	3.20	0.80	0.53	0.53	1.07
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	46.84	4.38	1.31	1.75	0.44	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	56.47	3.64	1.82	0.91	1.37	1.82
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	29.09	2.24	2.24	0.00	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	41.42	2.16	0.72	1.44	0.36	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	38.84	3.74	0.00	2.30	1.15	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	32.29	1.65	1.18	1.89	0.71	0.94
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	45.32	4.44	0.32	0.32	0.63	0.95
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	34.75	2.46	0.31	1.85	0.62	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	33.98	2.89	0.32	0.64	0.00	1.28
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	29.83	5.74	1.15	0.76	0.38	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	33.89	2.36	0.79	1.97	0.39	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	28.74	2.27	0.00	0.76	0.00	3.03
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	54.60	4.82	1.61	0.80	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	64.35	4.20	0.70	4.90	0.00	2.10
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	101.18	7.01	1.00	6.01	1.00	1.00
Cardiac Myocyte, donor1	11525-119I4	135.25	18.28	1.83	0.00	3.66	5.48
Cardiac Myocyte, donor2	11605-120I3	62.75	3.95	0.49	1.48	1.98	0.49
Cardiac Myocyte, donor3	11686-122I3	57.77	2.00	0.74	0.84	0.11	1.26
Chondrocyte - de diff, donor1	11261-116G1	44.03	2.77	2.08	0.00	0.00	1.73
Chondrocyte - de diff, donor2	11338-117F6	54.73	3.20	0.36	0.36	0.00	1.78
Chondrocyte - de diff, donor3	11410-118E6	62.81	4.55	0.80	0.46	0.80	0.91
Chondrocyte - re diff, donor2	11339-117F7	110.12	12.53	0.00	0.00	0.90	2.69
Chondrocyte - re diff, donor3	11411-118E7	88.97	4.85	2.02	0.00	1.21	1.62
Ciliary Epithelial Cells, donor1	11242-116D9	67.94	7.00	1.72	0.46	0.57	1.72
Ciliary Epithelial Cells, donor2	11323-117D9	58.79	7.70	2.14	1.50	1.28	3.21
Ciliary Epithelial Cells, donor3	11399-118D4	67.70	6.99	1.86	0.35	0.71	1.77
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	89.22	7.43	1.65	3.21	0.55	1.93
Corneal Epithelial Cells, donor1	11526-119I5	70.26	3.29	0.22	0.00	0.00	0.22
Corneal Epithelial Cells, donor2	11606-120I4	48.92	17.06	1.14	0.00	0.00	2.28
Corneal Epithelial Cells, donor3	11687-122I4	51.64	4.86	1.28	0.00	1.02	2.30
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	114.25	6.44	3.14	0.33	0.83	1.49
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	150.45	2.84	1.26	1.26	1.58	1.26
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	131.13	10.35	0.00	0.00	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	93.20	7.24	1.84	0.97	0.86	1.08
Dendritic Cells - plasmacytoid, donor1	11228-116C4	147.25	30.41	3.76	0.68	1.37	9.57
Dendritic Cells - plasmacytoid, donor2	11309-117C4	186.72	24.81	3.92	0.00	0.00	10.45
Dendritic Cells - plasmacytoid, donor3	11385-118B8	184.87	44.52	6.29	0.00	0.97	15.49
Endothelial Cells - Aortic, donor0	11207-116A1	80.05	8.17	2.84	1.33	0.17	2.00
Endothelial Cells - Aortic, donor1	11263-116G3	78.63	3.52	0.00	2.35	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	119.91	5.66	1.13	3.11	0.28	0.85
Endothelial Cells - Aortic, donor3	11412-118E8	85.71	3.54	2.36	1.18	0.00	1.97
Endothelial Cells - Artery, donor1	11264-116G4	91.63	2.33	0.00	2.91	0.87	1.75
Endothelial Cells - Artery, donor2	11341-117F9	117.40	4.24	1.88	4.71	1.18	1.18
Endothelial Cells - Artery, donor3	11413-118E9	88.88	5.43	1.40	1.40	0.53	0.70
Endothelial Cells - Lymphatic, donor1	11236-116D3	107.06	6.43	2.88	1.77	0.89	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	102.23	5.17	1.22	3.04	0.30	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	106.28	3.10	0.85	1.69	0.28	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	112.02	8.62	0.59	2.08	0.30	3.86
Endothelial Cells - Microvascular, donor2	11342-117G1	64.04	3.12	0.52	1.56	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	71.46	4.25	1.70	1.28	0.28	0.85
Endothelial Cells - Thoracic, donor1	11266-116G6	136.04	8.40	2.00	3.60	0.00	1.20
Endothelial Cells - Thoracic, donor2	11343-117G2	98.01	4.72	1.05	2.10	2.10	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	104.86	6.83	0.99	1.62	0.62	1.86
Endothelial Cells - Umbilical vein, donor2	11324-117E1	110.15	4.56	1.09	1.09	0.65	1.09
Endothelial Cells - Umbilical vein, donor3	11400-118D5	122.25	4.64	0.98	1.34	1.59	0.61
Endothelial Cells - Vein, donor1	11267-116G7	63.70	2.28	1.14	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	87.31	0.70	0.00	0.70	0.70	0.70
Endothelial Cells - Vein, donor3	11416-118F3	110.06	3.77	0.47	1.88	1.10	1.26
Eosinophils, donor1	12244-129H3	213.46	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	1189.84	3.30	16.50	28.05	1.65	3.30
Eosinophils, donor3	12246-129H5	1127.12	3.57	14.27	28.53	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	61.33	2.93	0.73	0.24	0.00	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	37.44	6.24	0.00	0.00	0.00	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	53.78	4.52	1.23	0.82	1.23	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	31.97	3.28	0.77	0.77	0.66	1.64
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	45.83	3.36	0.33	0.43	0.33	1.08
Fibroblast - Aortic Adventitial, donor1	11245-116E3	60.76	4.37	1.21	0.73	0.49	0.85
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	37.67	2.32	1.36	0.55	0.41	0.96
Fibroblast - Aortic Adventitial, donor2	11326-117E3	57.59	4.64	1.05	0.42	1.05	0.63
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	20.29	1.05	0.26	0.79	0.26	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	84.05	5.65	0.66	0.33	0.00	1.66
Fibroblast - Cardiac, donor1	11268-116G8	61.24	4.54	0.00	0.00	0.00	1.81
Fibroblast - Cardiac, donor2	11345-117G4	65.94	1.52	1.52	0.76	0.00	0.76
Fibroblast - Cardiac, donor3	11417-118F4	85.32	7.25	1.42	0.95	1.10	1.89
Fibroblast - Cardiac, donor4	11452-119A3	82.14	6.67	3.33	0.30	0.00	1.52
Fibroblast - Cardiac, donor5	11456-119A7	64.59	4.82	0.63	0.63	0.63	1.52
Fibroblast - Cardiac, donor6	11460-119B2	63.82	3.34	0.61	1.36	0.61	0.91
Fibroblast - Choroid Plexus, donor1	11492-119E7	90.58	8.04	1.61	0.54	0.27	2.68
Fibroblast - Choroid Plexus, donor2	11572-120E6	57.38	6.47	0.00	0.00	0.43	3.88
Fibroblast - Choroid Plexus, donor3	11653-122E6	64.45	7.32	1.46	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	83.03	3.46	1.15	0.92	0.23	2.31
Fibroblast - Conjunctival, donor3	11692-122I9	47.83	7.29	1.19	0.34	0.68	2.04
Fibroblast - Dermal, donor1	11269-116G9	58.46	4.93	1.41	0.70	0.23	2.35
Fibroblast - Dermal, donor2	11346-117G5	54.71	3.77	0.94	0.00	0.47	0.94
Fibroblast - Dermal, donor3	11418-118F5	52.22	6.53	0.60	0.00	0.24	2.30
Fibroblast - Dermal, donor4	11450-119A1	38.77	2.26	0.00	1.02	0.34	0.34
Fibroblast - Dermal, donor5	11454-119A5	32.10	2.62	0.17	0.00	0.00	1.40
Fibroblast - Dermal, donor6	11458-119A9	43.69	4.22	0.32	1.14	0.65	0.49
Fibroblast - Gingival, donor1	11237-116D4	47.48	4.16	0.42	0.62	0.00	0.62
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	55.02	3.41	1.83	0.26	0.79	3.93
Fibroblast - Gingival, donor2	11318-117D4	49.81	5.14	1.32	0.40	0.66	0.92
Fibroblast - Gingival, donor3	11394-118C8	57.34	4.54	0.87	0.29	0.39	0.77
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	61.29	5.19	3.12	1.04	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	49.51	2.29	0.88	0.35	0.35	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	60.49	7.48	1.40	0.62	0.47	2.03
Fibroblast - Gingival, donor6 (control)	11922-125H5	43.14	6.63	0.95	0.68	0.81	2.16
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	20.47	0.71	0.35	0.00	0.00	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	44.75	4.09	1.02	0.29	0.00	1.02
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	49.36	9.82	1.23	0.27	0.41	2.86
Fibroblast - Gingival, donor8 (control)	11926-125H9	47.39	5.27	2.41	0.66	0.66	1.54
Fibroblast - Gingival, donor9 (control)	11927-125I1	54.00	5.58	1.76	0.15	2.05	1.61
Fibroblast - Lung, donor1	11270-116H1	40.78	1.36	1.36	1.36	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	38.80	7.46	1.49	1.49	0.00	2.98
Fibroblast - Lung, donor3	11419-118F6	69.85	10.76	0.63	0.42	0.63	2.53
Fibroblast - Lymphatic, donor1	11506-119G3	135.78	10.83	0.83	0.83	0.83	2.50
Fibroblast - Lymphatic, donor2	11586-120G2	65.74	1.40	1.40	0.00	0.00	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	48.70	3.92	0.56	0.56	0.00	0.56
Fibroblast - Mammary, donor1	11540-120B1	139.25	6.90	0.81	1.22	0.00	2.44
Fibroblast - Mammary, donor2	11620-122A9	35.95	0.00	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	77.43	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	42.48	3.69	0.97	0.97	0.39	0.58
Fibroblast - Periodontal Ligament, donor2	11319-117D5	50.21	4.55	0.91	0.61	0.30	0.91
Fibroblast - Periodontal Ligament, donor3	11395-118C9	58.75	6.73	0.92	0.92	0.00	2.75
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	63.73	4.96	1.53	0.76	0.00	2.29
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	63.72	5.67	0.27	0.27	1.89	1.89
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	68.08	5.45	0.81	0.93	0.81	1.16
Fibroblast - Pulmonary Artery, donor1	11250-116E8	60.57	5.97	0.99	0.33	0.55	1.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	94.69	12.60	1.83	0.61	0.61	3.45
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	59.47	6.68	1.34	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	54.56	4.74	0.00	0.40	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	23.42	1.39	0.20	0.40	0.20	1.39
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	45.65	5.15	2.13	0.89	0.71	0.89
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	59.13	5.72	0.39	0.20	0.39	1.77
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	24.67	1.20	0.00	0.60	0.30	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	86.90	5.40	1.08	0.86	0.54	1.40
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	29.36	2.28	0.76	0.00	0.00	0.76
Fibroblast - skin normal, donor1	11553-120C5	54.80	5.58	0.82	0.16	0.00	1.31
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	26.67	2.21	0.60	0.20	0.00	0.80
Fibroblast - skin normal, donor2	11561-120D4	90.01	2.81	0.70	0.80	0.30	1.11
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	31.13	1.81	0.30	0.00	0.00	1.81
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	55.42	5.63	0.91	0.25	0.41	0.99
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	90.95	14.19	2.22	0.17	0.17	4.62
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	22.99	1.97	0.00	0.00	0.00	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	74.25	4.15	0.75	0.85	0.21	0.75
Fibroblast - skin walker warburg, donor1	11554-120C6	61.40	5.90	1.01	0.34	0.17	2.02
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	54.10	2.82	0.31	0.94	1.10	1.25
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	110.80	22.16	0.00	0.00	44.32	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	41.83	30.50	6.10	0.00	0.87	11.33
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	58.42	3.64	3.29	0.35	0.17	1.04
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	71.05	4.16	1.30	0.26	1.04	1.04
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	71.03	5.88	2.04	1.53	0.51	1.02
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	43.64	9.19	0.77	1.53	0.00	3.83
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	31.90	12.12	1.91	0.00	0.00	2.55
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	74.45	11.98	1.14	0.00	1.14	2.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	63.70	9.93	1.10	0.00	1.10	2.21
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	50.23	5.25	1.60	0.00	1.14	2.05
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	60.23	7.93	1.98	0.99	0.99	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	50.49	9.25	1.59	0.53	0.79	2.38
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	37.83	7.18	2.28	0.33	1.30	1.30
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	65.45	4.42	0.44	0.44	1.33	3.54
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	52.85	5.51	0.99	0.57	0.28	1.70
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	56.65	5.42	0.99	0.62	0.86	1.48
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	52.65	7.52	0.81	0.81	1.61	2.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	74.58	4.58	0.74	0.50	0.37	0.62
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	83.75	7.06	0.97	0.55	0.97	0.83
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	63.23	4.88	0.61	0.61	0.61	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	69.14	2.74	0.23	1.14	0.46	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	61.66	3.61	0.25	0.87	0.50	0.87
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	82.40	2.84	0.22	1.31	0.87	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	58.21	2.66	0.30	0.00	0.30	1.18
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	50.87	4.77	0.64	1.11	0.64	1.75
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	67.92	4.24	0.45	0.22	0.00	0.89
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	47.38	4.44	1.01	0.00	0.60	2.02
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	54.62	7.97	1.53	0.34	0.34	3.05
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	58.08	6.74	0.62	0.89	0.27	1.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	44.64	5.51	0.94	0.73	0.10	1.56
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	47.48	5.98	0.68	0.17	0.00	1.02
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	59.42	6.09	1.11	0.89	0.44	1.99
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	55.99	5.74	0.75	0.42	0.17	1.16
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	56.76	4.70	1.02	0.41	0.41	1.63
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	62.51	5.78	1.65	0.41	0.62	1.24
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	53.15	4.96	0.81	0.35	0.35	1.15
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	56.70	6.84	1.17	0.83	0.50	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	48.05	3.09	1.32	0.66	0.44	1.10
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	63.71	6.27	1.11	0.25	0.00	1.11
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	60.78	7.13	2.11	0.81	0.32	1.78
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	49.39	4.17	0.64	0.32	0.32	1.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	54.01	6.25	1.14	0.57	0.47	1.42
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	56.15	6.64	0.47	0.00	0.00	0.79
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	56.26	7.91	0.61	0.61	0.00	1.82
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	57.81	7.84	0.94	1.05	0.42	1.78
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	54.01	4.39	0.66	0.22	0.44	1.10
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	60.88	5.33	1.96	0.56	0.00	1.40
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	56.02	7.04	1.02	0.46	0.65	2.69
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	48.67	5.88	0.27	0.80	0.27	2.41
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	59.52	5.51	0.92	1.84	0.15	1.84
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	57.13	7.90	1.17	0.78	0.39	2.85
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	61.53	7.05	1.36	0.00	0.00	1.36
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	47.75	8.66	0.92	0.37	0.55	1.47
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	50.44	7.68	1.10	0.88	0.66	0.88
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	79.34	9.92	2.98	0.00	0.99	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	50.26	6.86	0.92	0.13	0.26	1.32
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	52.46	5.45	1.61	0.20	0.61	1.41
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	59.22	10.42	1.02	0.51	0.25	2.03
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	73.65	9.55	1.59	1.19	0.40	2.59
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	57.78	5.85	0.77	0.31	0.31	1.39
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	58.72	11.05	1.23	0.61	0.20	3.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	45.06	7.82	0.94	0.31	0.31	1.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	32.21	8.19	1.98	0.57	0.00	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	55.34	9.22	0.92	0.00	0.46	5.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	34.65	4.95	0.00	0.00	4.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	63.05	8.12	1.93	0.00	1.93	1.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	51.34	8.02	3.21	1.60	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	38.25	6.96	1.74	0.00	3.48	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	62.82	6.84	2.60	0.98	0.98	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	60.12	8.24	0.82	0.41	2.88	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	19.99	0.00	0.00	0.00	3.33	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	57.33	5.31	1.12	1.12	0.84	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	63.08	4.90	0.98	0.33	0.33	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	45.30	5.87	0.00	1.68	0.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	66.48	7.63	0.64	0.64	1.27	3.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	65.22	6.45	1.36	0.68	0.68	3.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	60.56	6.26	0.00	0.00	0.00	6.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	84.19	7.45	2.29	1.15	0.57	5.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	66.00	4.14	1.48	0.30	1.18	0.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	37.27	6.78	1.69	1.69	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	68.76	10.77	1.24	0.41	2.07	4.14
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	64.44	8.98	1.38	1.84	1.38	2.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	36.88	5.27	0.00	0.00	5.27	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	66.12	5.77	1.15	0.00	0.38	3.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	52.16	6.19	0.33	0.00	0.98	2.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	42.81	4.68	0.00	0.00	0.00	4.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	86.30	6.16	0.77	1.54	2.70	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	72.92	7.19	1.71	0.34	0.34	2.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	47.21	0.00	0.00	0.00	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	79.27	3.30	0.47	0.47	0.00	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	71.21	3.02	0.00	0.60	1.81	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	62.57	3.05	0.51	0.51	0.00	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	65.01	5.58	1.99	0.80	2.79	1.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	91.27	3.45	0.99	0.00	0.99	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	66.10	3.54	1.18	0.00	1.18	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	79.93	4.08	0.58	0.00	1.75	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	68.47	2.19	0.44	0.00	1.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	66.97	2.54	0.00	0.85	1.70	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	62.68	7.16	0.60	1.19	0.00	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	75.21	8.25	1.46	1.94	0.97	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	53.64	3.42	0.00	1.14	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	62.37	2.49	2.08	0.00	1.66	2.08
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	51.72	4.50	1.12	0.00	2.25	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	53.60	3.17	1.27	0.63	0.00	1.59
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	51.38	5.01	0.84	0.42	2.09	1.67
Hep-2 cells mock treated, biol_rep1	11898-125E8	39.34	11.72	2.20	0.58	0.81	3.25
Hep-2 cells mock treated, biol_rep2	11899-125E9	35.45	12.15	2.70	0.68	0.51	4.73
Hep-2 cells mock treated, biol_rep3	11900-125F1	42.77	15.47	2.28	1.59	0.00	3.41
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	32.36	12.24	3.17	0.87	0.55	2.95
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	36.96	16.33	3.01	0.64	0.21	3.65
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	37.24	12.06	2.80	0.22	0.43	2.80
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	40.72	13.33	2.24	0.50	0.25	2.62
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	39.11	12.01	2.92	0.86	0.51	4.46
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	34.92	10.57	2.24	0.32	0.32	2.24
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	82.26	4.48	1.12	0.00	1.12	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	71.41	1.73	0.43	0.00	0.00	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	71.38	2.64	0.00	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	92.77	7.41	2.12	0.35	0.00	1.06
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	61.75	11.62	2.91	0.73	0.73	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	56.30	3.85	0.87	0.52	0.52	1.22
Hepatocyte, donor1	11523-119I2	53.27	4.84	0.00	1.21	1.21	0.00
Hepatocyte, donor2	11603-120I1	34.47	11.85	3.23	0.00	1.08	1.08
Hepatocyte, donor3	11684-122I1	51.54	6.75	0.61	0.00	1.23	3.07
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	71.14	6.53	0.65	1.96	2.61	3.26
Intestinal epithelial cells (polarized), donor1	11246-116E4	200.47	26.74	8.39	2.27	1.40	3.67
Iris Pigment Epithelial Cells, donor1	11530-119I9	74.78	4.12	0.27	0.41	0.27	1.65
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	28.66	3.18	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	26.70	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	16.61	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	12.51	2.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	23.74	0.00	0.00	0.00	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	10.25	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	27.61	3.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	15.01	1.67	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	14.52	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	7.94	1.32	0.00	0.00	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	26.61	4.43	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	15.71	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	13.86	1.89	0.63	0.00	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	29.39	3.09	0.00	0.00	0.00	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	18.74	1.29	0.00	0.65	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	19.32	1.61	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	20.37	1.63	0.00	0.81	0.00	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	21.83	3.78	0.84	0.00	0.42	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	22.50	2.41	0.00	0.00	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	24.93	2.77	0.00	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	14.63	2.36	0.00	0.94	0.47	0.94
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	24.49	2.72	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	23.67	3.23	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	36.84	6.35	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	19.13	0.00	0.00	0.00	0.00	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	34.63	3.65	0.00	1.82	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	19.99	2.86	0.00	0.00	1.43	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	23.23	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	24.38	1.85	0.00	0.00	0.31	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	19.32	5.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	15.72	0.00	0.00	0.00	0.00	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	15.99	0.70	0.00	0.00	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	19.92	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	19.45	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	21.80	1.74	0.00	0.00	0.00	2.62
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	11.25	2.25	0.00	2.25	0.00	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	34.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	23.47	2.13	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	20.78	1.39	0.00	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	8.55	5.70	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	12.89	5.52	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	15.13	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	12.69	1.06	0.00	0.00	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	38.51	4.49	1.47	0.98	0.16	0.57
Keratinocyte - epidermal, donor2	11349-117G8	21.08	1.17	0.59	0.00	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	51.49	6.15	0.47	0.66	0.19	1.14
Keratinocyte - oral, donor1	11251-116E9	58.69	5.34	0.79	0.45	0.45	1.02
Keratocytes, donor1	11527-119I6	138.22	8.60	1.03	0.69	0.00	1.72
Keratocytes, donor2	11607-120I5	31.64	4.69	1.17	0.00	0.00	2.34
Keratocytes, donor3	11688-122I5	55.92	3.36	0.20	0.79	1.58	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	505.52	41.76	17.58	15.39	0.00	4.40
Lens Epithelial Cells, donor1	11529-119I8	53.94	3.24	1.08	1.08	0.00	2.16
Lens Epithelial Cells, donor2	11609-120I7	93.19	5.77	0.92	0.92	0.12	2.19
Lens Epithelial Cells, donor3	11690-122I7	69.02	5.95	1.01	0.61	0.20	2.52
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	98.89	6.17	2.02	0.71	0.71	1.78
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	53.86	5.30	2.23	1.12	0.56	1.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	68.63	3.94	2.20	0.79	1.42	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	63.45	3.23	1.08	0.54	0.00	1.61
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	58.31	2.21	1.89	0.32	0.95	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	71.48	5.28	1.08	1.51	1.19	1.62
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	70.59	4.92	0.82	2.46	0.41	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	59.92	5.56	1.01	0.76	0.76	1.01
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	72.49	4.93	1.41	1.41	1.97	1.13
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	56.96	3.56	1.19	1.58	0.79	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	56.42	4.85	1.55	1.16	1.36	1.55
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	67.21	4.63	0.93	1.30	1.85	0.93
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	79.09	4.18	3.14	2.09	1.39	2.09
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	62.73	4.05	2.39	0.95	0.48	1.91
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	67.71	4.94	1.65	1.10	1.24	0.69
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	74.53	5.24	1.54	1.85	1.85	1.54
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	51.44	2.49	0.62	1.25	0.94	0.94
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	70.09	5.31	1.46	1.65	0.91	2.20
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	59.57	4.94	0.99	2.30	0.33	2.30
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	51.55	3.81	1.17	0.59	0.29	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	70.20	4.73	1.24	1.74	0.75	0.75
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	59.65	6.30	1.45	0.48	0.48	1.45
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	58.17	3.77	1.08	0.54	0.54	1.89
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	76.45	6.51	0.76	1.51	0.91	2.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	65.32	4.67	0.00	1.04	0.00	1.56
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	58.21	5.23	0.63	0.63	0.84	0.84
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	68.72	6.62	0.75	1.35	1.80	1.95
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	68.79	2.06	1.38	1.38	0.69	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	55.88	5.08	0.75	1.13	0.56	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	74.75	4.56	1.48	1.70	0.85	1.91
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	67.84	4.36	1.45	1.45	0.97	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	59.54	5.95	0.66	2.32	0.66	1.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	65.04	4.96	0.87	1.24	1.49	1.73
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	72.19	3.33	1.11	1.85	0.37	2.22
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	56.58	4.45	0.99	0.49	0.25	1.24
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	70.40	6.60	2.34	2.06	0.69	1.92
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	65.61	4.82	0.64	0.96	0.64	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	49.00	1.83	1.22	2.13	0.91	2.43
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	78.66	4.76	2.38	1.68	1.54	1.40
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	65.07	6.40	1.78	1.42	0.71	1.07
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	38.30	4.85	0.97	3.39	1.45	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	71.58	5.45	1.24	0.78	2.02	2.18
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	71.62	2.51	1.07	1.07	2.15	2.15
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	54.88	4.25	0.65	1.96	0.00	2.29
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	60.50	5.41	1.18	1.65	0.71	0.71
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	102.22	6.56	0.99	1.73	0.37	1.98
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	57.63	2.82	1.79	0.26	1.28	0.77
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	103.23	3.58	0.90	1.19	0.60	1.79
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	43.05	6.80	0.00	2.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	49.10	10.74	2.30	1.53	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	40.82	6.68	2.97	1.48	1.48	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	29.62	11.00	2.12	1.69	0.85	1.27
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	42.90	10.55	4.22	1.41	0.70	3.52
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	36.42	7.47	1.87	2.80	0.00	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	24.73	8.24	0.52	1.03	2.58	1.55
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	40.44	4.76	1.19	0.00	0.00	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	36.87	7.69	2.71	0.68	0.23	2.94
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	26.76	11.05	2.62	0.87	0.29	3.49
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	32.86	15.31	1.35	0.45	0.00	4.50
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	42.68	12.06	1.76	0.95	0.27	1.90
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	29.78	5.65	2.05	0.00	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	45.87	9.17	1.76	0.71	0.35	1.76
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	42.64	7.33	2.00	1.33	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	28.02	6.62	2.04	0.51	0.51	3.57
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	55.76	13.61	1.87	1.07	0.00	2.93
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	50.26	13.04	2.65	1.51	1.13	3.59
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	33.13	6.75	1.23	0.61	0.61	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	61.97	8.97	3.26	1.63	1.63	3.26
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	43.31	10.41	3.54	2.29	1.25	1.67
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	36.71	10.93	2.52	0.56	1.96	1.96
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	54.61	7.21	1.03	3.09	0.00	3.09
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	50.51	13.64	3.48	0.58	0.87	1.74
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	31.39	8.67	1.79	1.20	0.30	2.09
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	55.88	12.17	2.77	2.77	0.00	2.21
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	41.36	13.08	3.53	1.41	2.47	1.06
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	28.76	11.80	3.32	1.11	1.11	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	37.99	12.66	5.76	0.00	0.00	2.30
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	41.06	9.98	1.92	0.38	0.77	2.30
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	25.48	10.76	1.70	1.13	0.00	2.26
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	46.77	8.20	0.82	1.64	0.00	4.10
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	51.51	9.94	1.81	0.45	1.81	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	30.88	8.62	1.44	1.44	0.00	2.87
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	56.76	12.70	2.24	1.49	0.00	2.24
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	55.74	9.29	1.86	1.11	0.74	2.97
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	46.09	8.18	2.58	0.43	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	43.67	11.99	0.86	0.86	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	47.31	15.66	4.33	1.00	1.67	1.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	34.39	7.24	2.41	1.21	0.60	1.81
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	46.21	15.64	1.42	0.00	0.00	2.13
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	42.28	11.69	3.78	2.06	1.03	1.72
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	32.20	8.59	4.83	0.54	0.00	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	50.50	14.14	0.00	0.67	0.00	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	35.56	12.96	4.07	2.22	0.74	1.85
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	59.31	12.79	2.33	1.16	1.16	3.49
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	44.43	10.58	2.12	0.00	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	52.02	11.20	4.40	0.00	0.80	1.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	31.26	5.81	0.73	0.00	0.00	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	48.29	11.50	0.77	0.77	0.77	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	36.50	10.36	0.99	0.49	0.99	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	31.99	7.53	3.76	0.00	0.00	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	45.25	8.05	3.02	1.51	0.50	2.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	42.36	13.52	1.35	0.90	0.45	2.25
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	15.49	1.72	0.00	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	56.56	14.25	2.67	1.78	0.45	2.23
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	41.45	10.56	1.17	1.17	1.56	1.17
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	32.33	5.94	2.64	1.32	0.66	3.30
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	49.82	12.45	2.08	1.04	1.56	2.59
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	49.01	9.63	2.63	1.31	0.88	5.25
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	31.87	6.15	2.24	0.00	0.00	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	48.58	11.04	2.65	0.88	0.88	1.77
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	51.69	14.27	3.09	1.16	1.54	2.70
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	33.42	13.17	1.52	2.53	0.51	3.04
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	62.00	10.09	2.88	1.44	0.96	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	47.31	11.93	1.19	0.80	1.99	1.99
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	40.10	9.72	0.00	1.22	0.00	3.04
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	31.82	10.38	3.46	0.69	0.00	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	52.06	12.54	3.42	0.76	0.76	1.14
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	30.99	10.84	1.03	1.55	3.10	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	47.16	10.88	3.63	0.60	0.60	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	49.44	11.73	5.07	2.85	1.27	1.27
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	30.92	8.00	3.20	0.00	2.13	3.20
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	37.35	8.62	3.45	2.30	0.00	2.30
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	52.45	12.86	4.63	1.54	3.09	2.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	43.15	12.73	0.71	1.41	0.71	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	49.94	11.92	0.00	3.40	1.70	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	56.16	17.06	1.25	2.50	0.83	3.33
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	36.80	10.96	3.13	0.00	0.00	3.92
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	41.75	10.02	1.67	2.09	0.00	1.67
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	53.90	9.29	2.79	0.93	0.46	1.86
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	41.48	8.70	2.01	3.35	1.34	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	47.58	6.95	1.07	1.07	0.53	3.21
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	51.32	13.34	3.23	1.21	0.81	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	36.71	7.34	1.84	1.84	0.92	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	54.24	9.78	3.56	2.67	1.78	4.45
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	60.98	8.55	2.28	3.42	1.14	2.85
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	35.28	11.50	2.30	3.83	0.00	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	42.68	10.40	4.38	2.19	0.00	1.64
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	56.13	13.36	2.67	2.67	0.89	2.23
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	59.79	14.56	3.64	3.12	1.30	3.90
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	51.72	11.94	2.65	3.98	0.00	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	72.75	8.31	6.24	0.00	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	74.76	3.19	0.00	0.46	0.46	0.23
Macrophage - monocyte derived, donor2	11313-117C8	109.37	4.22	1.28	1.65	0.73	0.37
Macrophage - monocyte derived, donor3	11389-118C3	115.74	4.72	1.05	1.31	0.79	0.79
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	54.70	6.37	3.19	0.00	0.00	1.06
Mallassez-derived cells, donor2	11929-125I3	80.65	4.91	1.27	0.79	0.63	1.74
Mallassez-derived cells, donor3	11930-125I4	81.86	5.28	1.25	1.11	0.00	1.53
Mammary Epithelial Cell, donor1	11273-116H4	47.23	5.48	1.49	0.40	0.40	2.29
Mammary Epithelial Cell, donor2	11350-117G9	44.59	6.37	0.58	0.29	0.58	2.90
Mammary Epithelial Cell, donor3	11422-118F9	35.67	5.49	0.25	0.50	0.50	1.00
Mast cell - stimulated, donor1	11487-119E2	265.07	9.49	7.46	2.03	3.39	2.71
Mast cell, donor1	11563-120D6	67.26	0.97	0.76	0.97	0.22	1.08
Mast cell, donor2	11565-120D8	151.56	3.86	1.49	2.97	1.19	0.89
Mast cell, donor3	11566-120D9	151.28	4.50	0.68	1.35	1.58	0.45
Mast cell, donor4	11567-120E1	141.83	3.37	1.42	1.42	0.18	0.71
Mast cell, expanded and stimulated, donor5	11940-126A5	54.45	1.55	0.44	2.11	0.67	0.55
Mast cell, expanded and stimulated, donor8	11942-126A7	59.54	1.75	2.33	1.17	0.58	0.00
Mast cell, expanded, donor5	11939-126A4	38.66	0.57	0.00	0.80	0.57	0.11
Mast cell, expanded, donor8	11941-126A6	54.23	2.68	0.50	1.00	0.50	0.33
Melanocyte - dark, donor1	11502-119F8	87.16	4.18	1.29	0.50	0.40	1.29
Melanocyte - dark, donor2	11582-120F7	67.49	3.81	0.69	0.35	0.00	2.77
Melanocyte - dark, donor3	11663-122F7	66.28	8.33	0.87	0.65	0.14	2.75
Melanocyte - light, donor1	11274-116H5	35.73	3.76	0.24	0.24	0.24	0.71
Melanocyte - light, donor2	11351-117H1	25.25	2.05	0.00	0.68	0.00	0.68
Melanocyte - light, donor3	11423-118G1	30.35	3.47	2.60	0.00	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	39.67	7.81	1.35	0.94	0.52	1.15
Melanocyte, donor2 (MC+2)	12739-135I3	33.08	10.76	2.15	0.54	0.54	2.15
Melanocyte, donor3 (MC+3)	12837-137B2	55.71	3.21	0.54	0.54	0.54	0.80
Meningeal Cells, donor1	11493-119E8	141.80	10.55	1.36	1.12	0.12	2.85
Meningeal Cells, donor2	11573-120E7	166.82	8.80	3.96	0.44	0.88	1.32
Meningeal Cells, donor3	11654-122E7	53.14	6.03	1.55	0.90	0.57	1.71
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	64.45	4.56	0.29	0.29	0.57	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	44.58	4.73	1.01	0.60	0.70	2.21
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	30.23	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	35.32	2.62	0.00	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	50.23	5.74	0.72	1.44	0.00	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	58.02	4.87	0.64	0.64	0.21	1.48
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	32.67	3.52	2.01	2.01	0.50	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	61.75	3.08	0.88	0.44	0.88	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	56.26	5.84	0.00	0.73	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	51.97	3.27	0.41	1.43	0.20	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	58.73	5.54	0.69	0.28	0.00	1.80
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	84.38	7.06	0.74	0.37	0.74	1.86
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	50.00	4.34	1.32	0.26	0.79	1.58
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	52.52	2.97	0.30	0.30	0.30	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	35.03	0.00	0.00	0.00	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	55.71	3.20	1.28	2.56	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	66.28	2.13	1.42	0.71	0.00	1.77
Mesenchymal stem cells - hepatic, donor0	11218-116B3	73.49	3.13	1.25	0.00	0.00	2.50
Mesenchymal stem cells - umbilical, donor0	11214-116A8	44.99	1.45	0.00	0.73	0.73	1.45
Mesothelial Cells, donor1	11247-116E5	120.92	8.49	3.45	2.39	0.00	2.12
Mesothelial Cells, donor2	12156-128G5	111.60	6.01	3.00	0.50	0.00	2.50
Mesothelial Cells, donor3	11402-118D7	85.34	9.97	2.02	1.23	1.30	1.37
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	429.40	5.40	6.75	1.35	1.35	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	156.88	7.88	0.99	1.48	1.48	2.96
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	100.70	7.95	1.77	1.77	0.88	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	217.80	6.91	3.46	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	107.55	4.34	0.31	0.93	0.62	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	82.56	5.19	1.24	0.83	0.62	1.24
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	196.86	9.26	6.95	6.95	0.00	4.63
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	123.13	4.25	0.75	0.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	109.85	8.38	2.33	1.86	0.47	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	291.99	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	119.90	4.47	1.63	0.81	0.81	1.83
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	87.51	4.75	3.56	1.58	0.79	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	384.82	8.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	61.95	2.65	0.00	1.77	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	85.11	4.94	1.90	0.76	0.76	1.14
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	351.35	5.26	5.26	6.58	1.32	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	118.85	4.67	2.33	1.70	0.85	2.12
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	79.19	7.37	1.84	0.00	0.00	2.76
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	122.50	6.56	1.79	2.38	1.19	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	196.17	1.68	0.00	1.68	0.00	8.38
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	950.58	0.00	33.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	133.48	5.77	2.51	2.01	1.25	1.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	79.38	4.52	1.66	0.95	0.95	0.95
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	355.50	11.06	2.76	6.08	0.00	3.32
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	138.15	2.99	2.30	1.84	0.46	0.92
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	105.80	6.73	1.89	0.63	0.84	2.10
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	138.40	4.69	1.83	4.28	0.61	1.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	118.00	5.36	2.15	3.00	0.21	0.64
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	115.15	6.00	2.89	2.45	0.00	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	588.15	0.00	10.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	151.34	3.94	2.41	3.07	0.66	0.66
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	149.05	5.58	5.07	1.52	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	376.14	11.60	3.31	1.66	0.00	3.31
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	197.59	3.53	3.26	2.72	1.36	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	114.10	6.47	3.23	0.00	1.18	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	291.12	9.81	1.09	4.36	0.00	2.18
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	119.18	2.88	1.44	0.96	1.92	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	105.66	5.60	1.60	1.60	0.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	346.92	6.86	1.37	4.11	0.00	2.74
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	169.20	3.00	2.00	3.00	1.00	2.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	161.68	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	303.74	12.23	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	158.97	5.69	1.75	4.82	0.88	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	335.51	9.93	3.31	5.52	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	300.34	7.68	3.84	4.48	0.64	1.92
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	167.59	5.45	1.98	2.98	1.24	1.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	256.09	5.57	2.09	1.39	0.70	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	483.96	13.26	0.00	6.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	146.32	3.76	1.03	3.42	1.71	1.71
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	229.31	6.56	1.75	3.50	0.44	0.88
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	276.97	9.23	0.36	1.42	0.36	2.84
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	157.95	6.73	2.24	2.81	0.28	3.09
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	214.05	7.90	3.33	2.08	0.42	1.66
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	264.57	6.41	1.17	2.91	0.00	2.91
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	134.84	6.94	3.32	2.41	0.90	2.11
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	189.08	4.17	1.25	3.34	0.83	1.25
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	490.88	14.44	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	161.62	7.39	0.92	2.77	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	203.74	6.26	3.98	1.14	0.00	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	171.90	5.94	2.07	1.93	1.11	2.63
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	139.16	3.37	1.30	1.55	0.26	2.85
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	208.91	9.44	2.57	2.14	0.43	3.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	233.12	5.08	1.27	3.18	0.00	3.81
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	161.20	6.41	2.40	2.40	0.53	1.07
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	169.12	5.09	3.29	1.50	1.20	3.29
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	131.79	4.94	1.27	1.13	0.99	0.99
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	118.81	6.05	2.23	3.19	0.64	2.23
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	220.47	7.96	3.32	3.32	0.66	2.43
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	212.35	9.48	1.52	1.90	0.76	2.28
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	128.13	3.41	1.14	1.99	0.28	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	184.11	7.37	3.44	2.95	0.74	2.70
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	194.85	6.52	1.96	1.30	0.65	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	145.84	5.00	1.47	1.47	0.00	2.06
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	192.89	4.61	2.02	1.73	1.15	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	182.58	4.12	1.65	0.82	0.41	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	170.33	3.87	1.79	0.60	0.00	0.89
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	45.20	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	69.51	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	93.31	2.30	0.99	0.99	1.97	0.99
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	63.12	1.05	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	56.34	1.19	0.00	0.40	0.40	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	82.89	3.73	0.00	0.00	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	92.38	3.00	1.13	1.13	0.75	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	85.23	3.73	0.80	0.27	0.00	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	65.15	1.81	0.45	0.90	0.11	0.45
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	47.89	1.47	0.74	0.00	0.00	2.21
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	82.45	1.83	0.37	0.37	1.10	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	68.45	3.11	0.00	1.56	3.11	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	75.36	3.21	0.53	0.53	1.07	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	54.09	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	79.79	0.00	1.01	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	87.28	4.22	0.42	1.26	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	88.53	5.45	4.09	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	111.90	2.54	2.54	1.27	1.91	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	123.10	5.67	0.81	0.81	0.00	1.62
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	69.48	1.51	4.53	1.51	0.00	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	239.83	0.00	28.55	5.71	0.00	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	208.80	19.57	22.84	0.00	0.00	6.52
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	232.87	9.50	4.75	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	75.29	12.55	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	73.68	4.74	0.86	0.86	0.86	2.37
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	50.17	4.18	0.52	0.00	0.52	2.61
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	14.02	0.67	0.00	0.00	0.67	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	22.96	4.17	1.25	0.42	0.00	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	67.69	3.04	1.14	0.00	0.57	2.09
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	140.44	9.58	4.79	4.79	0.00	3.19
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	9.52	0.68	0.00	0.00	0.00	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	75.34	3.68	0.00	1.84	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	11.30	1.67	0.00	0.00	0.42	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	28.82	4.42	0.23	0.23	0.00	1.86
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	16.75	1.62	0.00	0.27	0.00	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	42.89	3.36	0.63	0.21	0.63	1.05
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	122.48	0.00	0.00	0.00	22.27	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	19.36	1.49	0.00	0.00	0.00	1.49
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	23.82	1.35	1.08	0.00	0.27	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	13.15	1.59	0.23	0.00	0.00	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	16.66	0.98	0.65	0.00	0.49	0.82
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	53.22	3.10	0.91	0.00	0.73	1.09
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	18.03	1.06	0.00	0.53	0.53	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	13.81	1.80	0.60	0.60	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	58.42	6.89	1.31	0.00	0.98	2.95
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	17.08	2.28	0.65	0.16	0.33	0.65
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	68.26	3.17	0.88	0.88	0.53	0.88
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	20.39	2.81	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	22.07	2.30	1.38	0.00	0.00	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	17.35	2.89	0.64	0.00	0.32	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	74.50	7.24	2.07	0.34	0.34	5.52
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	202.28	2.53	0.00	0.00	2.53	7.59
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	71.07	4.68	1.34	0.22	0.00	1.11
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	21.59	1.69	0.42	0.00	0.00	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	28.01	2.61	1.19	0.24	0.00	2.85
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	19.75	2.15	0.86	0.00	0.86	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	108.33	18.06	0.00	0.00	18.06	18.06
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	31.32	1.33	2.00	0.00	0.33	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	56.81	4.96	0.45	0.90	0.45	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	14.68	1.19	0.40	0.00	0.79	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	14.86	3.71	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	37.08	3.03	0.00	0.00	0.38	1.89
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	23.14	2.28	0.33	0.33	0.65	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	27.89	0.87	0.44	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	83.22	4.07	0.45	1.36	0.00	2.26
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	17.64	0.88	0.00	0.00	0.00	1.76
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	18.62	2.66	0.00	0.00	1.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	20.34	2.48	0.00	0.50	0.00	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	17.99	1.15	0.38	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	39.92	1.81	0.60	0.30	0.00	0.91
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	53.71	3.54	0.66	1.11	0.00	0.88
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	18.97	2.71	1.36	0.00	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	117.52	0.00	0.00	0.00	0.00	10.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	26.83	2.44	0.61	0.00	0.61	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	22.98	2.20	0.00	0.63	0.00	1.26
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	25.73	0.61	0.00	0.30	0.30	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	14.24	2.37	0.00	0.00	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	66.88	5.67	0.00	0.00	0.00	4.53
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	91.04	5.06	5.06	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	45.34	1.99	0.50	0.87	0.37	1.24
Myoblast, donor2	11322-117D8	54.28	6.90	0.96	0.19	0.96	1.73
Myoblast, donor3	11398-118D3	52.63	3.36	0.34	0.84	0.50	1.18
NK T cell leukemia cell line:KHYG-1	10777-110G3	73.84	1.90	0.44	0.88	0.29	0.44
Natural Killer Cells, donor1	11230-116C6	85.80	1.54	0.62	1.54	0.31	0.62
Natural Killer Cells, donor2	11311-117C6	72.98	4.22	1.51	1.21	1.81	1.21
Natural Killer Cells, donor3	11387-118C1	87.24	4.05	0.92	0.92	0.74	1.66
Neural stem cells, donor1	11275-116H6	86.02	18.87	4.72	0.73	0.00	6.17
Neural stem cells, donor2	11352-117H2	88.58	5.78	1.93	0.00	0.00	3.85
Neurons, donor1	11494-119E9	70.55	6.83	0.00	1.14	0.00	1.14
Neurons, donor2	11574-120E8	60.77	3.52	0.44	1.54	0.22	0.44
Neurons, donor3	11655-122E8	41.11	5.76	2.47	0.82	2.47	1.64
Neutrophils, donor1	11233-116C9	318.31	1.86	2.78	8.35	7.42	0.93
Neutrophils, donor2	11314-117C9	159.44	0.00	0.00	8.70	2.90	0.00
Neutrophils, donor3	11390-118C4	317.64	1.83	2.44	17.71	1.83	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	60.91	5.46	1.07	0.12	0.24	2.61
Nucleus Pulposus Cell, donor2	11409-118E5	35.17	4.88	0.65	0.00	0.00	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	61.57	8.42	0.40	0.20	0.60	1.60
Olfactory epithelial cells, donor1	11933-125I7	35.65	7.30	3.03	0.00	0.69	1.65
Olfactory epithelial cells, donor2	11934-125I8	38.36	3.91	0.72	0.43	2.75	2.17
Olfactory epithelial cells, donor3	11935-125I9	38.48	4.43	1.36	0.34	0.79	1.14
Olfactory epithelial cells, donor4	11936-126A1	50.94	6.43	0.68	0.19	0.78	1.75
Oligodendrocyte - precursors, donor1	11496-119F2	113.14	6.02	0.00	0.00	0.60	2.41
Osteoblast - differentiated, donor1	11276-116H7	48.92	5.53	1.49	1.06	0.21	1.28
Osteoblast - differentiated, donor2	11353-117H3	45.72	2.29	0.00	0.00	3.43	3.43
Osteoblast - differentiated, donor3	11425-118G3	39.73	7.45	0.00	0.00	1.86	1.24
Osteoblast, donor1	11277-116H8	60.59	5.67	1.17	0.59	0.39	1.56
Osteoblast, donor2	11354-117H4	50.57	5.62	0.00	0.70	0.00	2.11
Osteoblast, donor3	11426-118G4	65.23	5.87	0.89	1.24	0.53	0.89
Pancreatic stromal cells, donor1	11249-116E7	54.50	5.39	0.93	0.51	0.67	1.94
Pericytes, donor1	11491-119E6	71.99	5.34	1.00	0.33	0.11	1.78
Pericytes, donor2	11571-120E5	95.07	9.28	2.49	0.23	1.13	2.72
Pericytes, donor3	11652-122E5	60.22	5.09	0.41	0.20	0.41	1.83
Perineurial Cells, donor1	11499-119F5	67.25	5.09	0.79	0.45	0.00	0.90
Perineurial Cells, donor2	11579-120F4	91.46	6.99	1.10	0.37	0.28	1.66
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	116.02	5.10	1.27	1.59	0.96	2.55
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	114.11	2.94	1.71	1.22	2.20	2.20
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	113.50	3.75	1.55	1.16	1.94	1.16
Placental Epithelial Cells, donor1	11278-116H9	99.97	5.02	2.15	1.67	0.48	1.91
Placental Epithelial Cells, donor2	11355-117H5	55.44	4.44	1.11	0.00	1.11	2.22
Placental Epithelial Cells, donor3	11427-118G5	72.84	6.68	2.16	0.39	0.39	0.98
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	41.77	4.11	0.32	0.00	0.63	0.63
Preadipocyte - breast, donor1	11467-119B9	35.64	2.63	0.94	0.00	0.75	0.94
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	27.54	1.31	0.26	0.26	0.13	0.78
Preadipocyte - breast, donor2	11328-117E5	51.33	3.15	0.68	0.90	0.90	1.13
Preadipocyte - omental, donor1	11468-119C1	46.14	4.16	0.75	0.32	0.21	2.24
Preadipocyte - omental, donor2	11329-117E6	60.23	4.36	1.75	1.31	0.00	0.87
Preadipocyte - omental, donor3	11403-118D8	68.76	6.45	1.15	0.57	0.57	2.01
Preadipocyte - perirenal, donor1	11469-119C2	75.79	5.91	2.95	0.98	1.97	1.97
Preadipocyte - subcutaneous, donor1	11279-116I1	43.92	2.15	0.00	1.23	0.31	1.23
Preadipocyte - subcutaneous, donor2	11356-117H6	72.60	3.72	1.24	1.42	0.35	1.59
Preadipocyte - subcutaneous, donor3	11428-118G6	67.77	4.77	0.34	0.34	0.68	1.87
Preadipocyte - visceral, donor1	11280-116I2	56.07	5.50	1.12	0.75	0.28	2.89
Preadipocyte - visceral, donor2	11357-117H7	54.30	6.90	2.76	0.00	0.92	4.60
Preadipocyte - visceral, donor3	11429-118G7	60.60	3.45	1.25	0.73	0.94	1.57
Prostate Epithelial Cells (polarized), donor1	11253-116F2	166.39	16.90	4.68	2.11	2.26	4.07
Prostate Epithelial Cells, donor2	11331-117E8	55.79	3.25	0.95	0.81	1.22	1.62
Prostate Epithelial Cells, donor3	11404-118D9	38.09	2.02	1.04	0.18	0.24	0.55
Prostate Stromal Cells, donor1	11254-116F3	60.25	3.99	1.25	1.03	0.34	2.16
Prostate Stromal Cells, donor2	11332-117E9	65.80	5.20	1.97	1.61	1.26	1.43
Prostate Stromal Cells, donor3	11405-118E1	75.60	6.57	1.46	0.31	1.04	2.19
Renal Cortical Epithelial Cells, donor1	11516-119H4	99.28	4.38	1.46	0.36	0.00	1.09
Renal Cortical Epithelial Cells, donor2	11596-120H3	57.53	3.05	0.42	0.49	0.21	0.55
Renal Epithelial Cells, donor1	11517-119H5	79.13	6.59	0.51	0.00	0.00	1.52
Renal Epithelial Cells, donor2	11597-120H4	78.25	4.98	0.71	0.00	0.71	2.85
Renal Epithelial Cells, donor3	11678-122H4	54.94	5.19	0.74	0.32	0.42	1.38
Renal Glomerular Endothelial Cells, donor1	11514-119H2	109.62	2.72	1.36	2.72	1.36	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	102.15	3.50	1.08	2.02	0.40	0.94
Renal Glomerular Endothelial Cells, donor3	11675-122H1	56.83	7.10	0.44	1.78	0.67	0.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	57.89	3.33	0.67	1.33	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	79.67	6.60	1.10	0.66	0.00	1.76
Renal Mesangial Cells, donor2	11598-120H5	70.85	6.27	0.00	0.00	0.63	1.25
Renal Mesangial Cells, donor3	11679-122H5	55.76	4.16	0.28	0.55	0.55	1.66
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	110.59	7.78	1.07	1.88	0.81	1.34
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	54.82	2.11	2.53	0.42	0.42	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	73.67	8.49	0.58	0.77	0.39	1.74
Retinal Pigment Epithelial Cells, donor0	11215-116A9	70.52	3.63	0.78	0.52	0.26	1.30
Retinal Pigment Epithelial Cells, donor1	11528-119I7	79.59	13.64	1.71	1.99	0.28	3.41
Retinal Pigment Epithelial Cells, donor2	11608-120I6	55.57	5.15	0.00	0.00	0.00	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	28.10	7.03	1.25	0.75	0.50	2.51
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	90.07	8.82	3.07	1.20	0.53	1.07
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	51.82	5.36	1.79	0.00	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	21.46	5.50	1.10	0.55	0.55	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	87.01	12.18	1.16	0.00	0.58	3.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	75.02	6.24	1.69	0.78	0.00	2.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	53.82	6.85	1.09	0.40	1.19	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	62.13	7.92	1.12	0.45	0.45	1.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	90.18	6.82	1.49	0.74	0.50	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	56.06	6.76	1.28	0.93	0.93	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	61.25	9.01	1.62	0.00	0.69	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	52.71	5.75	0.41	1.10	0.27	1.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	51.58	5.45	1.51	0.30	0.76	1.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	59.31	4.30	1.08	0.54	0.18	1.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	54.94	5.31	0.72	0.29	0.43	1.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	54.62	5.58	0.97	0.32	0.54	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	65.94	7.52	2.21	0.00	0.66	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	47.99	3.63	0.19	0.57	0.57	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	59.81	6.80	0.93	0.37	1.02	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	51.67	10.15	2.25	0.38	0.38	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	77.90	8.10	1.06	1.19	0.13	1.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	64.63	7.01	1.27	0.10	0.58	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	60.15	7.45	1.91	0.95	0.57	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	72.09	7.48	0.96	0.85	0.53	1.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	52.42	7.29	0.84	0.84	0.56	1.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	62.04	8.03	1.03	0.68	0.00	1.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	53.97	5.65	1.64	0.91	0.36	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	50.77	6.87	0.74	0.25	0.61	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	60.98	6.85	1.21	0.67	1.48	2.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	38.68	6.37	0.71	0.24	0.47	2.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	47.22	6.55	0.99	0.20	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	57.99	6.31	1.17	0.23	2.34	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	60.96	6.22	1.04	0.83	0.41	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	50.88	10.18	1.33	0.44	3.10	1.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	53.27	7.52	2.51	0.21	0.84	2.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	55.72	5.25	1.21	0.13	0.40	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	71.01	9.37	2.72	0.51	0.34	3.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	62.85	7.90	3.28	0.39	0.96	2.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	50.38	4.64	0.69	0.69	0.00	2.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	63.10	12.48	1.92	0.14	0.82	3.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	61.40	8.87	2.30	0.16	1.81	3.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	52.49	4.77	0.51	0.85	0.34	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	76.05	9.17	1.78	0.30	0.74	1.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	66.37	10.40	2.67	0.80	1.07	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	62.08	6.91	0.83	0.41	0.28	2.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	68.57	8.10	0.48	0.71	1.19	1.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	71.35	8.67	2.02	1.01	0.40	1.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	55.09	8.29	1.13	0.47	0.38	2.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	56.25	11.18	1.75	0.00	2.10	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	68.00	9.37	1.51	0.00	0.30	2.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	62.66	6.85	0.98	0.24	0.73	1.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	77.00	10.48	3.06	0.15	0.73	2.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	61.45	12.78	0.61	0.00	0.61	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	56.36	6.93	1.81	0.60	0.00	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	64.46	7.46	2.04	0.45	0.23	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	81.18	7.19	2.10	0.00	0.30	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	57.27	6.49	2.36	0.71	0.94	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	53.36	9.82	1.49	0.21	0.85	1.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	64.91	7.81	3.00	0.00	0.00	0.60
Schwann Cells, donor1	11498-119F4	92.72	5.08	1.13	0.94	0.38	0.75
Schwann Cells, donor2	11578-120F3	30.62	3.40	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	56.30	4.82	0.66	1.10	0.66	1.31
Sebocyte, donor1	11220-116B5	110.65	3.29	0.55	1.10	1.10	1.10
Sebocyte, donor2	11301-117B5	52.85	3.68	1.84	0.00	2.30	0.92
Sebocyte, donor3	11378-118B1	63.07	5.15	0.62	1.03	0.82	0.62
Sertoli Cells, donor1	11255-116F4	89.46	8.28	3.31	0.00	0.00	1.66
Sertoli Cells, donor2	11333-117F1	25.42	0.00	2.82	0.00	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	41.09	1.50	0.44	0.26	0.35	0.79
Skeletal Muscle Cells, donor2	11358-117H8	41.92	2.17	1.45	0.00	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	43.47	5.85	0.00	0.84	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	52.94	2.04	1.10	0.47	0.47	0.79
Skeletal Muscle Cells, donor5	11455-119A6	47.12	2.68	0.30	0.30	0.45	1.49
Skeletal Muscle Cells, donor6	11459-119B1	53.56	4.00	0.77	0.46	0.77	0.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	54.06	1.89	0.50	0.38	0.25	0.63
Skeletal Muscle Satellite Cells, donor2	11321-117D7	55.65	2.28	0.29	0.57	0.86	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	66.27	5.75	1.39	0.69	0.30	1.69
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	71.61	5.22	1.60	0.76	0.42	1.60
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	43.43	2.17	0.00	0.72	0.00	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	40.73	3.85	1.38	0.00	0.96	0.55
Skin - palm, donor1	10286-104F7	134.31	45.66	8.06	0.00	0.00	21.49
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	29.41	1.73	0.29	0.29	0.29	0.72
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	26.17	0.82	0.00	0.82	1.64	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	21.68	1.82	0.78	0.52	0.26	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	43.37	3.20	1.25	1.25	0.28	0.83
Small Airway Epithelial Cells, donor2	11334-117F2	57.95	3.24	1.41	0.70	0.70	1.13
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	50.96	3.59	0.63	0.00	0.00	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	59.81	3.00	1.65	0.60	0.67	0.67
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	61.72	1.54	0.00	2.16	0.93	1.23
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	23.57	0.89	0.22	0.00	0.44	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	68.19	2.35	2.35	0.00	0.59	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	92.15	3.31	0.66	0.88	0.44	1.33
Smooth Muscle Cells - Aortic, donor2	11360-117I1	85.84	2.76	0.79	0.79	0.00	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	67.99	6.18	1.55	0.77	0.77	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	38.03	8.01	2.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	77.05	4.66	0.93	0.53	0.53	0.93
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	58.30	6.87	1.11	0.66	0.66	4.43
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	74.51	5.51	1.66	1.15	1.02	1.15
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	67.07	3.91	1.30	0.00	0.65	1.63
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	51.98	5.91	2.95	0.00	0.30	1.77
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	60.50	2.85	1.28	0.71	0.28	1.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	65.56	3.90	0.49	0.33	0.16	0.98
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	60.58	5.78	0.91	0.91	0.61	2.74
Smooth Muscle Cells - Carotid, donor1	11285-116I7	72.49	5.05	2.27	0.25	0.00	3.28
Smooth Muscle Cells - Carotid, donor2	11362-117I3	201.98	0.00	0.00	0.00	12.24	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	68.66	4.29	0.95	0.48	1.43	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	40.26	2.80	1.18	0.29	0.15	0.88
Smooth Muscle Cells - Colonic, donor2	11320-117D6	49.29	3.23	1.08	0.43	0.43	1.29
Smooth Muscle Cells - Colonic, donor3	11396-118D1	54.16	3.67	0.73	0.84	0.52	1.05
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	97.91	6.96	1.86	1.39	0.77	1.39
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	68.98	3.23	0.00	1.08	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	63.66	4.48	2.39	1.79	1.20	1.49
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	95.59	4.10	0.34	0.00	0.68	1.37
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	59.68	2.20	0.71	0.31	0.47	0.39
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	41.16	9.26	1.11	0.30	0.60	3.62
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	108.54	6.83	2.28	2.28	1.82	1.82
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	66.42	6.04	0.60	1.21	0.60	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	63.85	6.89	1.32	0.53	0.53	1.59
Smooth Muscle Cells - Prostate, donor1	11257-116F6	68.04	5.73	1.07	0.13	0.13	2.66
Smooth Muscle Cells - Prostate, donor2	11335-117F3	58.10	3.38	0.50	0.75	1.13	1.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	40.08	4.31	0.51	0.00	0.76	1.52
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	77.35	5.13	0.90	0.45	1.06	2.11
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	70.52	3.75	1.50	0.00	0.75	2.25
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	394.13	3.88	0.00	2.58	11.63	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	59.06	2.33	0.47	0.93	0.47	3.26
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	79.77	7.07	2.02	1.51	1.01	1.51
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	72.39	5.01	0.31	0.94	2.82	1.25
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	55.46	7.08	0.88	0.59	0.29	1.18
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	81.22	5.66	0.75	0.92	0.42	1.83
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	59.80	3.74	0.93	0.00	0.00	1.87
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	70.95	5.61	1.44	0.58	0.00	2.73
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	73.43	3.57	1.78	0.00	0.00	0.76
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	49.64	4.14	0.38	0.00	0.75	1.69
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	70.85	3.77	0.42	0.98	0.28	1.26
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	60.75	4.36	0.92	0.34	0.08	1.09
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	29.52	0.48	0.00	0.00	0.95	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	71.69	6.61	0.73	0.73	0.49	1.96
Smooth Muscle Cells - Uterine, donor1	11258-116F7	73.58	9.06	1.55	0.66	0.44	2.65
Smooth Muscle Cells - Uterine, donor3	11466-119B8	44.76	2.34	0.88	0.29	0.00	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	43.93	1.55	1.36	0.19	0.39	2.14
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	37.02	2.12	1.06	1.59	0.53	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	27.52	1.86	0.00	0.00	0.00	1.49
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	43.12	1.44	0.36	0.36	0.36	1.08
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	23.56	2.56	0.57	0.57	0.00	2.27
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	31.12	3.15	0.79	0.39	0.79	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	30.73	3.30	1.02	0.25	0.25	1.02
Smooth muscle cells - airway, control, donor2	11967-126D5	31.95	1.60	0.80	0.00	0.40	1.60
Smooth muscle cells - airway, control, donor3	11968-126D6	34.69	1.67	0.42	0.00	0.00	2.09
Smooth muscle cells - airway, control, donor4	11969-126D7	49.96	2.75	2.29	0.00	0.46	0.92
Synoviocyte, donor1	11291-117A4	57.57	7.24	2.19	0.34	0.84	2.36
Synoviocyte, donor2	11368-117I9	80.46	4.19	1.68	0.17	0.67	1.84
Synoviocyte, donor3	11440-118H9	63.90	3.80	0.67	0.00	0.67	1.34
Trabecular Meshwork Cells, donor1	11532-120A2	75.04	3.93	0.71	0.71	0.00	2.14
Trabecular Meshwork Cells, donor2	11612-122A1	49.55	1.98	0.00	0.00	0.00	3.96
Trabecular Meshwork Cells, donor3	11693-123A1	55.80	2.08	1.16	0.46	0.23	0.93
Tracheal Epithelial Cells, donor1	11292-117A5	37.28	2.58	0.65	0.14	0.36	0.72
Tracheal Epithelial Cells, donor2	11369-118A1	33.24	2.71	2.32	0.39	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	36.08	2.86	0.00	0.00	0.00	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	91.90	7.75	3.20	1.23	0.74	1.85
Urethra, donor2	10319-105A4	75.53	17.98	3.60	0.00	0.00	1.80
Urothelial Cells, donor1	11520-119H8	74.92	2.66	0.27	1.06	0.27	0.80
Urothelial Cells, donor2	11600-120H7	44.86	2.00	0.80	0.40	0.80	0.00
Urothelial Cells, donor3	11681-122H7	46.76	2.06	0.46	0.23	0.23	0.46
Urothelial cells, donor0	11216-116B1	66.42	2.67	0.89	0.45	0.45	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	201.98	2.67	0.00	8.01	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	230.17	1.43	2.86	7.15	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	119.11	0.68	0.00	3.42	2.05	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	106.06	0.34	0.34	2.75	0.00	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	85.41	1.16	0.58	2.91	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	170.76	1.04	1.04	4.16	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	221.19	0.92	0.00	3.67	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	130.54	0.00	1.83	9.13	1.83	0.00
Wilms' tumor cell line:G-401	10809-111A8	44.29	5.18	0.74	0.99	0.25	0.99
Wilms' tumor cell line:HFWT	10597-108E3	61.60	0.00	0.88	0.88	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	118.99	24.58	5.31	0.56	1.12	3.63
achilles tendon, donor2	10292-104G4	88.86	4.13	8.27	4.13	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	89.23	7.14	2.04	0.51	1.02	0.76
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	61.53	6.27	0.93	0.23	0.00	1.63
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	52.71	6.53	1.54	0.71	0.12	0.59
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	56.33	2.45	1.36	8.16	0.82	1.36
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	53.69	10.12	0.84	1.12	1.12	1.12
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	71.27	1.90	0.63	1.27	0.42	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	42.47	1.91	0.00	1.91	0.00	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	38.78	4.41	0.44	0.44	0.44	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	55.95	2.45	0.82	0.41	0.41	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	56.30	10.48	1.16	0.39	0.39	1.94
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	42.87	10.12	1.29	0.18	0.37	1.47
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	23.40	3.90	0.00	0.00	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	66.46	7.20	0.93	0.23	0.70	1.86
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	49.19	1.04	0.26	0.78	0.26	0.78
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	49.68	3.80	0.29	1.75	0.00	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	91.09	4.65	0.46	1.39	0.00	1.39
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	36.60	6.17	0.41	0.41	0.41	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	33.76	5.22	0.61	0.92	0.31	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	45.23	5.12	0.00	1.28	0.43	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	49.13	3.34	0.91	1.21	0.30	1.52
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	46.70	8.18	1.20	0.48	0.72	1.44
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	44.77	7.80	0.67	0.22	0.45	1.11
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	44.36	9.01	1.33	0.67	0.00	2.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	154.23	22.30	0.00	0.00	0.00	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	48.21	6.03	0.38	0.38	0.75	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	58.88	8.29	1.31	2.18	0.44	1.74
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	106.84	1.87	1.87	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	69.00	28.02	6.83	0.94	1.41	2.83
adipose tissue, adult, pool1	10010-101C1	78.02	5.43	1.24	0.47	0.16	0.62
adipose, donor1	10184-103D4	146.60	10.56	5.28	0.00	4.10	4.10
adipose, donor2	10185-103D5	38.52	5.68	1.22	0.41	1.22	1.62
adipose, donor3	10186-103D6	54.46	10.07	3.54	0.82	0.82	2.45
adipose, donor4	10187-103D7	127.41	47.67	10.40	0.00	2.60	6.07
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	48.29	1.10	0.00	1.10	0.32	0.47
adrenal gland, adult, pool1	10081-102A9	43.65	3.64	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	48.29	2.27	0.80	0.40	0.13	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	45.38	3.93	2.86	0.36	0.36	0.36
amniotic membrane cells, donor1	12235-129G3	100.85	16.93	3.94	0.23	0.00	2.32
amniotic membrane cells, donor2	12236-129G4	105.49	19.95	9.13	0.34	0.68	3.38
amniotic membrane cells, donor3	12237-129G5	132.28	15.61	7.37	1.18	1.18	1.47
amygdala - adult, donor10196	10167-103B5	97.24	5.93	0.00	1.19	1.19	2.37
amygdala, adult, donor10252	10151-102I7	150.05	4.66	1.42	1.82	0.61	0.41
amygdala, newborn, donor10223	10360-105E9	33.89	2.90	1.94	0.00	0.00	1.94
anaplastic carcinoma cell line:8305C	10428-106D5	130.13	5.09	1.91	0.89	0.76	0.76
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	48.32	4.41	1.54	2.43	0.44	1.32
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	55.12	3.67	1.34	0.33	0.00	0.33
aorta, adult, pool1	10052-101G7	89.44	6.86	1.96	0.59	1.77	0.59
appendix, adult	10189-103D9	106.34	8.15	3.49	1.16	1.16	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	71.88	16.85	4.47	0.34	0.34	3.44
artery, adult	10190-103E1	80.16	1.36	0.00	0.00	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	103.72	8.98	1.74	1.59	0.58	3.91
b cell line:RPMI1788	10427-106D4	73.46	4.01	1.19	0.30	0.15	0.89
basal cell carcinoma cell line:TE 354.T	10702-109G9	87.67	5.83	2.22	0.28	1.11	1.11
bile duct carcinoma cell line:HuCCT1	10432-106D9	110.74	6.35	2.08	2.18	0.40	1.69
bile duct carcinoma cell line:TFK-1	10496-107C1	109.47	1.34	0.84	9.54	0.33	0.50
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	42.50	1.68	0.56	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	137.54	5.87	1.52	0.43	0.43	0.87
blood, adult, pool1	10053-101G8	81.94	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	114.75	2.57	0.86	0.86	0.86	0.86
bone marrow, adult	10192-103E3	49.94	6.75	0.00	0.00	3.37	0.00
brain, adult, donor1	10084-102B3	89.18	1.03	0.00	2.05	1.03	0.00
brain, adult, pool1	10012-101C3	115.03	6.79	0.89	1.22	1.34	3.56
brain, fetal, pool1	10085-102B4	66.78	8.01	2.67	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	93.49	11.23	1.65	2.97	1.32	1.98
breast carcinoma cell line:MDA-MB-453	10419-106C5	140.18	38.57	5.49	1.87	0.62	5.99
breast, adult, donor1	10080-102A8	65.66	1.89	2.53	0.63	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	54.88	24.26	4.45	0.51	1.14	6.48
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	89.98	21.95	3.71	0.31	0.62	3.40
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	33.61	3.22	0.92	0.23	0.92	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	48.90	12.10	2.42	0.24	1.21	1.45
carcinoid cell line:NCI-H1770	10703-109H1	39.96	2.35	0.94	0.94	0.47	0.47
carcinoid cell line:NCI-H727	10735-110B6	175.12	15.20	5.14	1.86	0.88	3.94
carcinoid cell line:SK-PN-DW	10719-109I8	17.43	2.22	1.27	0.95	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	40.73	9.85	2.66	0.53	0.80	3.73
caudate nucleus - adult, donor10196	10177-103C6	67.93	3.45	0.00	2.30	0.00	2.30
caudate nucleus, adult, donor10252	10164-103B2	142.90	6.19	2.51	2.68	2.01	1.34
caudate nucleus, adult, donor10258	10379-105H1	67.24	3.06	0.00	1.53	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	29.66	3.66	1.46	2.56	0.37	0.37
cerebellum - adult, donor10196	10173-103C2	93.22	2.91	0.00	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	117.64	5.34	1.49	0.43	0.21	0.21
cerebellum, adult, pool1	10083-102B2	52.43	6.21	2.07	0.00	1.03	1.38
cerebellum, newborn, donor10223	10357-105E6	34.04	4.15	0.00	0.00	0.83	2.49
cerebral meninges, adult	10188-103D8	153.81	7.82	2.27	1.01	1.51	1.51
cerebrospinal fluid, donor2	10294-104G6	73.09	5.12	1.46	4.39	2.19	1.46
cervical cancer cell line:D98-AH2	10552-107I3	52.62	5.75	1.01	0.72	0.00	1.29
cervical cancer cell line:ME-180	10553-107I4	66.45	14.25	3.48	0.50	0.17	3.65
cervix, adult, pool1	10013-101C4	92.81	11.76	3.57	0.42	0.31	1.89
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	211.24	1.53	1.53	5.71	1.81	1.11
chondrosarcoma cell line:SW 1353	10700-109G7	82.29	6.53	0.00	1.31	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	65.24	5.22	0.75	1.49	0.37	0.75
choriocarcinoma cell line:SCH	10785-110H2	79.84	2.83	1.72	2.96	0.74	0.86
choriocarcinoma cell line:T3M-3	10618-108G6	60.95	2.37	0.95	2.13	0.24	0.95
chorionic membrane cells, donor1	12238-129G6	76.36	5.13	0.57	0.85	0.85	0.85
chorionic membrane cells, donor2	12239-129G7	82.53	7.86	1.89	0.10	0.89	1.09
chorionic membrane cells, donor3	12240-129G8	80.22	5.49	3.30	1.10	0.55	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	45.44	6.06	1.01	0.00	3.03	3.03
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	39.76	4.80	0.19	0.00	0.38	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	42.45	2.75	0.42	0.21	0.21	1.06
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	28.25	2.57	0.51	0.00	0.00	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	31.44	4.11	0.24	0.24	0.00	0.97
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	32.58	3.05	0.81	0.81	0.00	1.22
chronic myelogenous leukemia cell line:K562	10454-106G4	38.87	5.30	0.88	0.29	0.29	1.47
chronic myelogenous leukemia cell line:KU812	10409-106B4	37.79	1.04	0.52	0.26	0.00	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	83.20	0.69	0.23	0.69	2.51	0.46
clear cell carcinoma cell line:TEN	10636-108I6	140.54	14.75	6.42	2.08	0.69	2.78
colon carcinoma cell line:CACO-2	10513-107D9	166.75	42.65	5.49	2.20	0.55	8.05
colon carcinoma cell line:COLO-320	10420-106C6	65.75	16.34	0.76	0.00	0.38	3.42
colon, adult, donor1	10082-102B1	104.72	19.04	10.71	0.00	1.19	3.57
colon, adult, pool1	10014-101C5	158.75	17.04	6.11	0.82	0.71	2.94
colon, fetal, donor1	10070-101I7	127.31	10.51	8.65	1.24	0.62	1.24
common myeloid progenitor CMP, donor1	12130-128D6	128.34	0.00	0.00	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	75.11	25.04	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	46.74	2.97	1.70	1.70	0.00	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	34.56	5.58	0.91	1.21	0.45	0.91
cord blood derived cell line:COBL-a untreated	10449-106F8	43.85	5.64	1.55	1.27	0.56	1.55
corpus callosum, adult, pool1	10042-101F6	102.27	5.31	0.88	1.66	0.11	0.44
cruciate ligament, donor2	10295-104G7	128.05	5.67	7.29	1.62	3.24	0.81
diaphragm, fetal, donor1	10069-101I6	44.14	6.42	1.61	0.00	0.00	0.80
diencephalon, adult	10193-103E4	105.83	2.64	0.24	3.36	0.96	0.96
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	47.07	2.76	1.15	0.69	0.69	1.38
ductal cell carcinoma cell line:KLM-1	10438-106E6	123.09	23.85	5.90	1.54	0.26	4.62
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	39.24	2.41	0.72	1.20	0.24	0.72
ductus deferens, adult	10196-103E7	91.69	17.44	7.48	0.00	2.99	3.99
duodenum, fetal, donor1, tech_rep1	10071-101I8	37.45	7.20	2.88	0.00	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	64.74	15.45	3.68	0.74	2.94	2.21
dura mater, adult, donor1	10041-101F5	128.84	13.13	2.81	0.66	0.66	5.04
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	62.18	14.88	4.66	3.33	0.00	8.66
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	38.55	6.30	2.01	1.00	0.57	3.58
embryonic pancreas cell line:1B2C6	10604-108F1	171.42	8.02	3.70	2.47	3.70	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	71.74	1.21	0.61	0.61	1.21	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	113.00	3.09	1.23	2.47	0.62	1.23
embryonic pancreas cell line:2C6	10603-108E9	249.56	9.19	0.00	0.00	0.00	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	140.45	11.06	2.68	2.68	1.34	2.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	58.18	3.81	0.36	1.45	0.36	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	85.23	6.11	2.57	1.13	1.13	1.93
epidermoid carcinoma cell line:A431	10426-106D3	183.63	18.45	5.67	1.45	0.44	4.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	147.38	20.68	4.07	2.09	0.33	3.19
epididymis, adult	10197-103E8	61.54	11.51	1.47	0.42	1.05	2.30
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	39.03	0.53	0.18	0.53	0.35	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	29.10	1.97	0.39	0.00	0.00	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	58.58	27.26	4.59	1.44	0.92	4.72
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	69.68	26.47	4.53	2.07	0.98	4.23
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	67.11	25.88	7.06	1.68	0.45	5.60
esophagus, adult, pool1	10015-101C6	107.35	21.87	6.69	0.53	0.85	4.14
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	35.32	0.50	0.13	0.63	0.13	0.00
eye - muscle inferior rectus, donor1	10272-104E2	120.73	4.83	0.00	0.00	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	86.27	2.10	6.31	2.10	2.10	2.10
eye - muscle medial, donor2	10299-104H2	102.69	7.44	1.49	0.00	0.00	2.98
eye - muscle superior, donor2	10297-104G9	82.55	6.88	2.29	2.29	1.15	2.29
eye - vitreous humor, donor1	10268-104D7	80.16	1.46	0.00	0.00	0.00	2.91
eye, fetal, donor1	10054-101G9	81.86	6.86	3.05	0.25	1.02	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	42.06	2.69	0.13	0.13	0.13	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	66.71	5.22	1.19	1.19	0.47	1.42
frontal lobe, adult, pool1	10040-101F4	127.98	8.73	1.22	1.31	0.56	2.81
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	134.51	16.81	3.90	1.80	2.10	4.80
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	82.11	1.10	0.91	0.82	0.27	0.09
gall bladder, adult	10198-103E9	120.23	15.69	4.83	1.45	1.45	2.17
gamma delta positive T cells, donor1	11937-126A2	47.24	1.61	0.00	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	53.78	2.61	0.37	0.75	0.37	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	64.21	9.50	2.32	0.84	1.27	2.75
gastric adenocarcinoma cell line:MKN45	10612-108F9	145.64	7.54	3.29	0.58	0.39	2.13
gastric cancer cell line:AZ521	10549-107H9	47.55	2.79	0.33	0.00	0.00	1.15
gastric cancer cell line:GSS	10560-108A2	34.78	1.83	0.92	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	42.72	8.00	0.91	0.00	0.69	3.88
giant cell carcinoma cell line:LU65	10487-107B1	47.62	1.38	0.34	1.03	0.11	0.46
giant cell carcinoma cell line:Lu99B	10433-106E1	69.42	2.10	0.28	0.00	0.28	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	58.11	6.98	2.24	1.25	0.25	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	110.30	10.66	4.33	2.43	0.53	2.53
glioblastoma cell line:A172, tech_rep2	10444-106F3	138.19	14.18	5.62	1.69	0.56	1.40
glioblastoma cell line:T98G	10485-107A8	72.07	14.68	3.31	0.66	0.33	2.65
glioma cell line:GI-1	10413-106B8	48.62	4.39	1.17	0.59	0.59	2.05
globus pallidus - adult, donor10196	10175-103C4	75.08	1.46	0.00	0.73	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	163.79	2.44	0.73	1.22	0.00	0.98
globus pallidus, adult, donor10258	10367-105F7	53.40	1.37	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	42.10	2.66	0.53	1.60	0.00	2.66
granulocyte macrophage progenitor, donor1	12131-128D7	301.00	14.68	2.45	0.00	0.00	4.89
granulocyte macrophage progenitor, donor2	12135-128E2	54.64	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	62.72	10.45	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	54.08	6.72	1.28	0.00	1.28	1.60
hIPS +CCl2, biol_rep1	14383-156B9	76.21	4.59	0.92	0.92	0.00	1.38
hIPS +CCl2, biol_rep2	14384-156C1	51.21	6.40	0.46	0.91	0.46	4.57
hIPS +CCl2, biol_rep3	14385-156C2	52.82	4.51	0.00	0.00	1.29	0.64
hIPS, biol_rep1	14380-156B6	45.99	1.44	0.00	0.00	0.00	5.75
hIPS, biol_rep2	14381-156B7	52.13	3.43	0.00	0.00	0.00	4.12
hIPS, biol_rep3	14382-156B8	61.79	2.21	0.00	0.00	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	50.29	2.01	0.00	0.86	1.44	0.00
heart - mitral valve, adult	10205-103F7	72.35	6.88	2.99	0.60	0.60	0.60
heart - pulmonic valve, adult	10206-103F8	80.01	6.28	2.61	1.31	1.05	1.31
heart - tricuspid valve, adult	10207-103F9	174.02	4.16	6.66	5.83	2.50	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	100.80	10.00	2.86	0.41	1.84	2.86
heart, adult, diseased, donor1	10051-101G6	120.51	2.55	1.28	0.85	3.41	0.00
heart, adult, pool1	10016-101C7	197.78	4.14	1.84	1.38	0.23	0.69
heart, fetal, pool1	10046-101G1	128.35	7.39	1.64	0.72	0.51	1.33
hepatic mesenchymal tumor cell line:LI90	10778-110G4	64.48	8.02	2.47	0.93	0.31	1.23
hepatoblastoma cell line:HuH-6	10633-108I3	117.73	14.27	4.76	4.76	0.00	2.38
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	134.69	19.45	4.20	1.77	0.66	3.65
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	141.28	25.97	6.07	1.58	2.18	5.70
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	139.35	22.43	3.94	2.12	2.32	5.15
hepatoma cell line:Li-7	10484-107A7	64.51	4.56	0.22	0.33	0.33	1.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	38.39	10.05	0.80	0.70	0.60	3.82
hippocampus - adult, donor10196	10169-103B7	82.33	3.79	0.95	1.89	1.89	1.89
hippocampus, adult, donor10252	10153-102I9	149.61	5.51	1.43	2.45	1.63	0.82
hippocampus, adult, donor10258	10374-105G5	79.67	3.49	0.00	1.00	0.00	5.48
hippocampus, newborn, donor10223	10363-105F3	28.90	2.82	0.70	1.41	0.35	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	49.44	6.10	0.61	0.61	1.22	2.44
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	33.97	3.73	0.79	0.59	0.79	1.37
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	37.58	7.11	1.27	1.02	0.76	2.29
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	30.45	4.51	1.13	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	44.41	6.20	1.03	0.26	4.39	1.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	38.72	6.45	1.52	0.76	0.76	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	39.41	6.71	0.88	0.58	0.58	2.04
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	38.78	4.52	2.37	0.43	0.43	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	29.20	7.51	0.42	0.00	0.00	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	39.54	7.10	2.13	1.42	0.24	2.37
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	40.18	6.27	1.61	0.48	0.64	2.89
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	43.09	8.08	2.02	0.00	0.00	2.69
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	32.86	7.04	0.16	0.16	1.56	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	44.22	5.90	0.49	0.98	0.98	1.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	24.44	6.11	0.87	0.87	0.00	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	43.15	8.21	0.57	0.00	0.57	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	41.86	6.11	1.31	0.00	0.00	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	42.98	6.00	0.50	0.00	1.50	2.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	42.76	3.01	0.57	0.57	0.94	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	50.02	5.91	0.91	0.45	0.45	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	42.29	3.76	0.31	0.63	0.94	2.19
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	41.48	3.59	1.14	0.16	0.16	3.10
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	43.84	3.48	0.87	1.16	0.87	2.90
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	37.66	6.28	0.90	0.60	0.00	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	39.17	6.47	0.74	0.18	0.74	0.92
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	36.23	5.14	0.86	0.00	0.57	0.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	51.86	6.53	2.04	1.22	1.22	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	51.40	5.99	1.76	0.35	1.06	1.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	41.81	4.12	0.32	0.00	0.32	1.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	31.47	10.29	0.00	0.00	1.82	1.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	38.78	3.62	0.52	0.00	1.03	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	39.85	5.98	1.33	1.33	1.33	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	38.22	8.21	1.28	0.00	0.51	2.31
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	52.15	7.93	1.28	0.51	1.02	3.07
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	37.10	6.82	3.79	1.51	0.00	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	27.89	8.07	0.67	0.67	0.34	6.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	42.51	6.52	1.45	0.48	0.48	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	23.17	5.35	1.34	0.00	1.34	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	39.51	3.41	0.00	0.00	0.98	1.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	38.20	7.33	0.61	0.31	0.61	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	133.38	19.52	0.00	0.00	6.51	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	40.04	6.95	1.65	0.66	1.32	2.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	32.84	6.57	2.19	0.55	0.55	2.74
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	32.93	4.70	1.81	0.72	1.09	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	29.89	6.76	1.42	0.71	0.00	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	32.22	5.97	2.39	1.19	1.19	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	54.44	7.72	1.35	1.22	0.54	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	31.25	5.12	0.54	0.81	1.08	2.69
immature langerhans cells, donor1	11904-125F5	267.33	9.44	6.78	2.91	1.45	4.36
immature langerhans cells, donor2	11905-125F6	85.55	12.67	8.71	1.58	0.79	7.92
insula, adult, pool1	10039-101F3	136.56	6.81	1.61	1.51	0.76	2.37
keratoacanthoma cell line:HKA-1	10791-110H8	47.15	33.17	7.48	0.33	0.33	3.25
kidney, adult, pool1	10017-101C8	86.91	8.51	1.90	1.70	0.70	1.60
kidney, fetal, pool1	10045-101F9	85.59	9.69	2.62	1.41	0.14	1.91
large cell lung carcinoma cell line:IA-LM	10509-107D5	138.33	8.24	1.28	1.28	0.43	3.12
large cell lung carcinoma cell line:NCI-H460	10839-111E2	30.14	5.94	1.38	0.28	0.83	1.80
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	52.11	5.50	1.10	0.73	0.00	0.73
left atrium, adult, donor1	10079-102A7	46.86	1.63	1.63	0.54	0.54	1.09
left ventricle, adult, donor1	10078-102A6	48.04	1.01	0.51	0.00	1.01	1.01
leiomyoblastoma cell line:G-402	10721-110A1	47.88	3.01	0.27	1.09	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	68.98	5.39	1.08	0.36	0.72	1.08
leiomyoma cell line:15242A	10570-108B3	52.72	3.26	0.00	1.09	0.00	1.63
leiomyoma cell line:15425	10571-108B4	64.35	4.37	0.97	0.49	2.19	1.70
leiomyosarcoma cell line:Hs 5.T	10722-110A2	95.24	0.00	0.00	0.00	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	120.24	9.41	4.18	0.00	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	64.22	2.83	0.35	0.47	0.47	0.35
liposarcoma cell line:KMLS-1	10782-110G8	68.11	2.19	1.09	0.62	0.47	1.09
liposarcoma cell line:SW 872	10726-110A6	89.92	21.93	3.66	0.61	0.49	2.56
liver, adult, pool1	10018-101C9	52.18	5.67	1.94	0.32	0.81	1.78
liver, fetal, pool1	10086-102B5	16.93	2.82	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	96.54	2.62	1.31	2.33	1.17	0.58
locus coeruleus, adult, donor10252	10165-103B3	121.07	4.24	0.55	1.85	0.74	0.37
locus coeruleus, adult, donor10258	10375-105G6	43.45	4.80	0.28	1.13	0.56	1.13
locus coeruleus, newborn, donor10223	10362-105F2	43.32	2.52	1.26	2.52	0.00	1.26
lung adenocarcinoma cell line:A549	10499-107C4	64.22	0.83	0.69	1.66	0.14	0.55
lung adenocarcinoma cell line:PC-14	10408-106B3	288.86	24.82	16.55	2.76	0.00	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	266.53	18.85	6.72	1.32	1.58	3.16
lung, adult, pool1	10019-101D1	119.19	4.84	2.48	1.42	0.24	0.59
lung, fetal, donor1	10068-101I5	173.81	16.55	3.42	1.71	0.57	5.42
lung, right lower lobe, adult, donor1	10075-102A3	58.65	5.04	1.83	1.37	0.46	1.37
lymph node, adult, donor1	10077-102A5	40.71	1.42	0.47	0.00	1.42	1.42
lymphangiectasia cell line:DS-1	10727-110A7	50.85	2.63	0.66	0.22	0.44	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	76.82	4.53	1.81	0.60	0.45	1.06
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	77.30	6.80	0.00	2.55	0.00	0.85
mature adipocyte, donor1	12231-129F8	117.21	14.65	4.00	1.33	0.89	0.44
mature adipocyte, donor2	12232-129F9	89.03	6.43	3.74	0.62	0.00	1.45
mature adipocyte, donor3	12233-129G1	84.16	9.48	3.08	1.19	0.47	1.90
mature adipocyte, donor4	12234-129G2	85.55	7.11	2.37	0.79	0.00	1.58
maxillary sinus tumor cell line:HSQ-89	10414-106B9	151.53	15.73	3.10	2.62	0.71	1.43
medial frontal gyrus - adult, donor10196	10170-103B8	122.96	9.02	1.13	1.13	0.00	6.77
medial frontal gyrus, adult, donor10252	10150-102I6	175.26	8.64	0.92	2.57	1.84	1.29
medial frontal gyrus, adult, donor10258	10368-105F8	79.10	4.45	0.95	0.95	0.95	2.22
medial frontal gyrus, newborn, donor10223	10352-105E1	65.68	5.97	0.43	4.69	0.00	2.56
medial temporal gyrus - adult, donor10196	10183-103D3	130.44	7.43	1.18	1.52	10.13	1.69
medial temporal gyrus, adult, donor10252	10156-103A3	180.82	6.58	1.91	1.70	0.64	2.33
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	61.64	1.93	0.00	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	200.95	0.00	0.00	14.35	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	39.12	3.23	1.08	2.15	0.00	1.08
medulla oblongata - adult, donor10196	10174-103C3	64.90	4.54	1.30	1.30	0.00	1.95
medulla oblongata, adult, donor10252	10155-103A2	113.47	3.25	1.70	1.39	1.08	1.08
medulla oblongata, adult, pool1	10038-101F2	111.83	6.37	2.04	1.22	0.33	0.90
medulla oblongata, newborn, donor10223	10361-105F1	37.84	3.47	1.74	1.74	0.00	0.35
medulloblastoma cell line:D283 Med	10838-111E1	31.66	3.99	0.89	0.22	0.44	1.55
medulloblastoma cell line:ONS-76	10759-110E3	86.08	7.34	0.86	1.22	0.61	1.35
melanoma cell line:COLO 679	10514-107E1	55.49	1.44	1.29	0.29	0.29	0.43
melanoma cell line:G-361	10465-106H6	52.66	6.24	0.81	0.54	1.36	0.00
meningioma cell line:HKBMM	10691-109F7	62.41	1.99	0.36	0.54	3.26	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	41.41	25.55	5.29	0.00	2.64	3.52
merkel cell carcinoma cell line:MS-1	10844-111E7	36.29	9.33	1.56	0.26	0.26	1.81
mesenchymal precursor cell - adipose, donor1	11747-123G1	74.42	5.06	1.38	0.31	0.46	1.23
mesenchymal precursor cell - adipose, donor2	11748-123G2	48.35	6.54	1.82	0.55	0.55	4.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	39.34	2.07	0.00	0.83	0.00	1.66
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	59.00	5.06	1.40	0.28	0.28	1.69
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	74.91	4.24	1.35	0.19	0.96	1.93
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	36.79	4.16	0.00	0.00	0.00	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	62.65	1.72	1.20	0.51	0.34	1.54
mesenchymal precursor cell - cardiac, donor2	11753-123G7	65.67	3.57	1.15	0.00	0.23	1.15
mesenchymal precursor cell - cardiac, donor3	11754-123G8	70.96	6.10	1.59	0.13	0.27	2.65
mesenchymal precursor cell - cardiac, donor4	11755-123G9	86.16	5.94	1.35	1.22	0.95	1.62
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	90.91	5.26	1.28	0.71	0.85	0.85
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	47.43	2.31	0.66	1.98	0.00	1.65
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	80.26	8.86	1.11	1.11	0.28	1.80
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	43.98	4.89	1.05	1.05	0.70	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	67.58	4.90	1.02	0.41	0.41	0.82
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	33.43	5.03	0.36	0.36	1.08	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	74.90	4.97	1.24	0.10	0.21	2.07
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	51.53	3.65	1.14	0.91	0.68	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	77.20	7.97	1.68	0.42	1.26	3.36
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	67.70	4.93	1.49	0.30	0.45	1.49
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	70.37	6.91	1.14	0.09	0.53	2.54
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	54.12	7.36	0.74	0.37	0.00	1.84
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	37.20	3.72	0.00	0.57	0.29	2.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	36.63	4.63	0.42	1.26	1.26	2.11
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	62.11	3.65	0.00	0.00	0.00	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	39.90	3.07	1.02	0.00	0.26	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	43.19	3.14	1.31	1.05	0.52	1.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	39.13	4.01	0.92	0.00	0.00	1.54
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	41.19	1.88	0.71	0.00	0.47	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	46.71	2.71	0.34	0.00	1.02	1.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	42.44	1.57	1.18	0.39	0.39	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	40.31	1.85	0.00	0.00	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	49.32	3.17	0.87	0.00	0.87	1.44
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	43.50	3.35	0.45	0.00	0.22	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	41.34	3.61	1.44	0.24	0.00	1.44
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	63.07	2.93	2.20	0.00	2.20	3.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	40.95	2.01	1.68	0.00	0.67	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	37.66	1.64	0.82	0.00	0.41	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	34.36	1.72	0.86	0.00	0.00	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	43.75	2.73	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	41.32	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	39.30	1.62	0.97	0.00	1.30	1.62
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	17.46	2.91	1.45	0.00	1.45	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	43.18	1.07	0.53	0.53	0.53	1.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	31.89	0.82	0.00	0.00	0.00	2.45
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	39.26	1.94	1.17	0.00	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	12.59	0.00	0.00	0.00	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	31.79	1.99	0.99	0.00	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	4.77	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	35.58	4.15	0.00	0.59	0.00	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	42.65	1.22	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	31.04	3.17	0.63	0.00	0.63	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	23.45	3.10	0.00	0.00	0.00	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	23.64	2.15	0.00	0.00	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	15.97	3.99	0.00	0.00	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	30.99	6.89	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	28.12	2.44	0.00	0.00	1.22	1.63
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	33.37	1.59	0.00	0.00	1.59	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	35.96	1.77	1.18	0.00	1.18	2.95
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	35.22	4.05	0.00	0.00	0.00	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	29.41	1.34	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	27.20	4.73	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	35.95	2.57	0.00	0.00	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	37.86	2.75	1.38	0.00	0.69	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	20.78	1.98	0.49	0.00	0.49	2.47
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	13.46	1.12	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	24.81	3.18	0.00	0.00	1.27	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	27.00	3.22	1.61	0.00	0.81	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	23.99	2.18	0.00	0.00	2.18	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	25.34	2.53	0.00	0.00	3.80	3.80
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	34.59	4.86	1.21	0.00	0.00	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	13.56	0.00	4.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	27.18	2.47	0.00	0.00	0.82	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	28.37	3.37	0.79	0.20	0.00	1.39
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	29.53	5.84	1.62	0.00	0.97	1.62
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	31.58	7.13	2.04	0.00	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	106.77	5.42	2.32	0.00	0.00	1.55
mesothelioma cell line:ACC-MESO-1	10493-107B7	136.08	1.18	0.00	1.65	0.24	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	84.33	5.10	1.16	1.85	0.23	0.70
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	81.20	12.82	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	72.75	7.40	2.16	0.62	0.92	1.54
mesothelioma cell line:Mero-25	10850-111F4	69.45	1.82	0.45	4.09	0.91	0.68
mesothelioma cell line:Mero-41	10851-111F5	91.19	13.20	5.13	0.98	0.24	2.44
mesothelioma cell line:Mero-48a	10852-111F6	105.84	6.42	0.89	2.21	1.55	1.55
mesothelioma cell line:Mero-82	10853-111F7	58.34	6.31	2.63	1.05	1.05	3.15
mesothelioma cell line:Mero-83	10854-111F8	56.85	9.87	2.55	1.70	0.34	1.53
mesothelioma cell line:Mero-84	10855-111F9	64.96	4.55	1.26	2.02	1.01	0.76
mesothelioma cell line:Mero-95	10856-111G1	90.27	11.59	1.66	0.41	1.04	2.69
mesothelioma cell line:NCI-H2052	10847-111F1	90.28	7.45	2.98	2.82	0.33	1.99
mesothelioma cell line:NCI-H226	10846-111E9	59.18	4.16	1.63	1.99	0.72	1.45
mesothelioma cell line:NCI-H2452	10848-111F2	80.80	5.47	1.20	2.22	0.34	0.85
mesothelioma cell line:NCI-H28	10845-111E8	40.71	2.29	0.25	2.04	0.25	0.00
mesothelioma cell line:No36	10857-111G2	35.23	4.57	0.98	1.30	0.33	1.30
mesothelioma cell line:ONE58	10858-111G3	73.70	10.03	3.79	1.35	0.54	7.04
migratory langerhans cells, donor1	11901-125F2	203.44	6.33	0.38	1.54	1.15	1.34
migratory langerhans cells, donor2	11902-125F3	170.84	4.52	1.34	0.85	0.61	0.49
migratory langerhans cells, donor3	11903-125F4	220.22	4.85	1.79	1.79	0.18	1.79
mixed mullerian tumor cell line:HTMMT	10689-109F5	62.36	2.94	0.65	0.65	2.61	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	70.36	2.97	0.64	0.64	0.42	1.48
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	139.37	3.23	1.15	0.92	0.00	1.38
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	49.29	3.62	0.57	1.14	0.19	1.14
myelodysplastic syndrome cell line:SKM-1	10772-110F7	75.03	5.17	1.11	1.29	0.37	1.11
myeloma cell line:PCM6	10474-106I6	46.25	13.84	2.37	1.19	0.00	2.97
myxofibrosarcoma cell line:MFH-ino	10600-108E6	117.18	11.67	4.06	0.51	0.00	2.54
myxofibrosarcoma cell line:NMFH-1	10684-109E9	160.25	3.73	2.16	0.78	0.20	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	31.42	1.56	0.45	0.22	0.00	0.45
nasal epithelial cells, donor1, tech_rep2	12226-129F3	29.20	1.47	0.74	0.15	0.07	0.44
nasal epithelial cells, donor2	12227-129F4	76.73	6.07	2.21	0.55	0.00	1.66
neuroblastoma cell line:CHP-134	10508-107D4	65.11	6.90	2.53	0.00	0.23	2.30
neuroblastoma cell line:NB-1	10539-107G8	75.96	9.73	2.06	0.94	0.00	2.43
neuroblastoma cell line:NBsusSR	10607-108F4	64.95	9.70	1.48	1.27	0.63	2.32
neuroblastoma cell line:NH-12	10555-107I6	38.57	9.69	1.12	0.19	0.56	1.86
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	35.11	5.22	0.95	1.19	0.47	1.19
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	43.08	5.70	1.43	1.74	0.48	1.11
neuroectodermal tumor cell line:TASK1	10774-110F9	42.06	3.82	1.01	0.40	0.00	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	82.01	8.90	1.91	0.64	0.00	1.27
neurofibroma cell line:Hs 53.T	10729-110A9	54.83	3.19	0.80	0.27	0.53	1.60
neutrophil PMN, donor1	12133-128D9	1472.61	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	119.53	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	293.59	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	161.68	2.03	2.03	0.17	1.18	0.51
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	74.45	4.80	0.80	0.80	0.00	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	43.60	6.41	1.28	0.00	0.64	1.28
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	49.93	5.52	1.58	0.00	2.36	2.10
nucleus accumbens, adult, pool1	10037-101F1	129.83	7.59	1.59	2.06	0.56	1.69
occipital cortex - adult, donor10196	10172-103C1	115.38	8.24	0.00	2.06	0.00	2.06
occipital cortex, adult, donor10252	10163-103B1	184.63	6.44	2.15	1.07	1.61	0.54
occipital cortex, newborn, donor10223	10355-105E4	50.22	5.10	1.09	1.46	0.00	3.28
occipital lobe, adult, donor1	10076-102A4	88.69	4.20	1.31	0.52	2.36	1.57
occipital lobe, fetal, donor1	10073-102A1	47.20	3.43	2.15	0.86	1.72	1.72
occipital pole, adult, pool1	10036-101E9	127.25	9.15	1.42	0.55	0.55	2.21
olfactory region, adult	10195-103E6	127.05	4.97	0.57	1.72	0.76	1.34
optic nerve, donor1	10277-104E7	86.05	2.00	0.00	0.00	4.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	104.11	9.34	1.94	1.25	0.80	2.16
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	88.06	5.36	0.69	0.55	0.14	1.24
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	59.43	10.16	3.89	0.85	1.19	1.52
oral squamous cell carcinoma cell line:SAS	10544-107H4	110.31	12.24	2.66	0.92	1.50	2.77
osteoclastoma cell line:Hs 706.T	10704-109H2	52.91	0.88	0.88	1.47	0.00	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	279.37	2.80	2.80	1.87	0.93	1.87
osteosarcoma cell line:HS-Os-1	10558-107I9	48.35	7.85	0.85	0.21	0.00	2.54
ovary, adult, pool1	10020-101D2	89.10	7.60	2.01	0.35	0.52	1.92
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	81.58	2.75	0.73	1.10	0.55	1.10
pancreas, adult, donor1	10049-101G4	67.73	10.35	2.82	0.94	0.00	2.82
pancreatic carcinoma cell line:NOR-P1	10698-109G5	54.51	6.71	1.12	1.96	0.84	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	84.32	14.31	4.43	2.38	1.87	4.26
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	156.64	12.09	2.65	1.66	0.66	1.32
paracentral gyrus, adult, pool1	10035-101E8	130.69	7.50	1.10	1.10	0.73	1.46
parietal cortex, adult, donor10258	10373-105G4	78.54	2.94	0.73	1.47	0.00	4.40
parietal lobe - adult, donor10196	10171-103B9	94.99	7.52	0.94	1.88	0.94	4.70
parietal lobe, adult, donor10252	10157-103A4	170.74	4.28	1.43	3.71	0.57	0.86
parietal lobe, adult, pool1	10034-101E7	144.43	5.82	0.70	1.32	0.26	1.59
parietal lobe, fetal, donor1	10072-101I9	64.98	3.88	0.00	0.97	1.94	2.91
parietal lobe, newborn, donor10223	10356-105E5	52.34	5.23	2.62	1.50	0.37	4.11
parotid gland, adult	10199-103F1	59.82	15.42	3.70	0.62	0.62	4.32
penis, adult	10200-103F2	76.81	8.59	1.07	0.54	1.61	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	40.35	0.93	0.19	3.72	0.93	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	87.27	7.43	1.46	0.73	0.44	1.75
pineal gland - adult, donor10196	10179-103C8	79.98	5.16	0.00	1.29	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	85.28	3.55	1.18	0.00	0.59	0.00
pineal gland, adult, donor10258	10377-105G8	37.00	0.63	1.25	0.00	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	78.92	15.18	1.01	2.02	0.00	3.04
pituitary gland, adult, donor10252	10162-103A9	129.77	10.94	1.04	1.04	0.00	4.17
pituitary gland, adult, donor10258	10378-105G9	54.48	16.17	0.85	0.85	0.00	9.36
placenta, adult, pool1	10021-101D3	104.17	14.84	2.80	1.08	0.11	2.37
plasma cell leukemia cell line:ARH-77	10840-111E3	50.85	4.63	1.32	0.79	0.53	1.85
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	90.27	9.03	2.49	0.47	0.78	0.62
pons, adult, pool1	10033-101E6	99.67	3.87	1.46	0.86	0.34	0.69
postcentral gyrus, adult, pool1	10032-101E5	129.28	8.80	1.05	1.74	0.78	1.74
promyelocytes/myelocytes PMC, donor1	12132-128D8	370.18	4.18	4.18	2.09	0.00	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	88.13	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	82.15	0.00	0.00	0.00	0.00	11.74
prostate cancer cell line:DU145	10490-107B4	57.10	5.97	0.29	0.87	0.58	1.02
prostate cancer cell line:PC-3	10439-106E7	166.62	16.34	5.08	1.82	1.27	2.90
prostate, adult, pool1	10022-101D4	114.18	6.44	3.08	0.45	0.27	1.09
putamen, adult, donor10196	10176-103C5	155.09	5.19	0.47	3.54	0.94	1.18
putamen, adult, donor10252	10152-102I8	147.05	0.00	0.00	7.84	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	45.90	3.28	0.00	2.19	0.00	3.28
putamen, adult, donor10258, tech_rep2	10372-105G3	81.66	2.42	0.24	3.14	0.48	1.21
putamen, newborn, donor10223	10365-105F5	22.49	0.75	1.50	3.75	0.00	2.25
rectal cancer cell line:TT1TKB	10469-106I1	118.70	7.56	4.36	2.04	0.29	0.87
rectum, fetal, donor1	10067-101I4	101.54	20.86	4.17	0.00	2.78	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	122.11	7.84	1.70	0.64	0.42	1.91
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	72.90	0.41	0.83	0.41	0.83	0.00
retina, adult, pool1	10030-101E3	81.81	10.83	2.29	0.60	0.50	1.89
retinoblastoma cell line:Y79	10475-106I7	53.52	5.20	0.52	0.26	0.52	1.04
rhabdomyosarcoma cell line:KYM-1	10787-110H4	44.26	3.81	0.00	0.61	0.00	0.86
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	137.51	15.18	6.19	0.84	0.28	2.25
sacrococcigeal teratoma cell line:HTST	10695-109G2	113.68	10.61	3.03	0.00	0.00	3.79
salivary acinar cells, donor1	11771-123I7	36.26	6.80	1.29	0.32	0.65	1.78
salivary acinar cells, donor2	11772-123I8	32.49	10.05	2.48	0.14	0.00	4.54
salivary acinar cells, donor3	11773-123I9	82.76	24.50	6.62	1.32	0.66	5.96
salivary gland, adult, pool1	10093-102C3	111.53	38.89	3.43	0.00	1.14	8.01
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	47.72	3.12	0.34	1.35	0.42	1.01
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	63.71	4.23	0.47	1.53	0.59	1.53
seminal vesicle, adult	10201-103F3	87.83	13.23	6.88	1.06	1.59	3.17
serous adenocarcinoma cell line:JHOS-2	10639-108I9	64.86	14.82	5.83	0.00	1.21	3.89
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	93.36	8.81	2.26	0.25	0.25	2.77
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	86.30	4.01	2.01	3.01	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	172.47	14.78	7.25	2.42	1.07	3.36
signet ring carcinoma cell line:Kato III	10436-106E4	69.96	11.72	3.21	0.88	0.55	2.54
signet ring carcinoma cell line:NUGC-4	10483-107A6	66.45	16.90	6.97	0.52	0.65	2.97
skeletal muscle - soleus muscle, donor1	10282-104F3	153.22	2.13	2.13	4.97	1.42	3.55
skeletal muscle, adult, pool1	10023-101D5	149.56	5.52	1.44	1.32	1.08	0.48
skeletal muscle, fetal, donor1	10066-101I3	23.12	5.03	1.01	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	27.14	27.14	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	65.02	9.47	2.52	0.00	1.89	2.52
small cell cervical cancer cell line:HCSC-1	10800-110I8	65.70	16.34	3.34	0.67	1.00	4.34
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	65.25	8.83	2.52	0.95	0.32	1.58
small cell lung carcinoma cell line:DMS 144	10841-111E4	34.50	0.39	0.00	0.96	0.39	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	40.05	8.41	2.14	0.33	0.00	2.31
small cell lung carcinoma cell line:NCI-H82	10842-111E5	31.85	0.48	0.16	0.48	0.16	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	99.37	21.79	3.92	0.87	0.65	8.72
small intestine, adult, pool1	10024-101D6	185.14	28.31	11.59	1.43	0.60	5.02
small intestine, fetal, donor1	10064-101I1	61.18	10.81	2.70	1.23	0.98	1.72
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	74.88	15.90	6.15	1.03	4.10	2.56
smooth muscle, adult, pool1	10048-101G3	152.23	9.05	3.62	0.78	1.03	0.52
somatostatinoma cell line:QGP-1	10781-110G7	102.12	7.24	1.61	0.54	0.27	3.48
spinal cord - adult, donor10196	10181-103D1	67.67	2.98	2.98	0.00	1.61	0.46
spinal cord, adult, donor10252	10159-103A6	108.42	2.37	0.39	1.18	0.39	0.00
spinal cord, adult, donor10258	10369-105F9	56.04	5.53	0.00	0.69	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	96.96	15.86	3.05	0.61	3.05	2.44
spinal cord, newborn, donor10223	10359-105E8	55.56	5.05	0.00	2.30	1.38	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	82.59	5.68	1.05	0.00	0.60	2.24
spleen, adult, pool1	10025-101D7	81.94	3.41	0.99	0.88	0.33	1.32
spleen, fetal, pool1	10044-101F8	93.36	4.53	1.35	0.87	0.32	1.27
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	87.67	5.59	1.35	1.35	0.41	0.93
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	49.18	2.28	0.95	0.19	0.00	0.76
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	89.46	20.27	2.45	0.70	1.75	5.59
squamous cell carcinoma cell line:T3M-5	10616-108G4	141.13	5.47	1.17	1.56	1.56	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	151.62	5.63	2.70	2.70	0.79	1.58
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	46.17	0.85	1.27	1.69	0.85	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	57.54	2.12	0.85	0.00	0.00	0.42
stomach, fetal, donor1	10062-101H8	153.79	36.31	9.61	0.00	0.00	7.48
submaxillary gland, adult	10202-103F4	54.12	17.09	7.41	0.00	0.57	5.13
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	54.27	0.00
substantia nigra, adult, donor10252	10158-103A5	98.45	2.08	1.45	1.66	1.04	0.21
substantia nigra, adult, donor10258	10371-105G2	68.28	3.10	0.00	2.07	0.00	3.10
substantia nigra, newborn, donor10223	10358-105E7	33.21	1.41	0.00	0.71	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	70.38	8.48	3.67	0.69	0.69	0.69
temporal lobe, adult, pool1	10031-101E4	134.02	7.04	1.27	1.44	0.42	2.37
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	108.26	4.27	1.42	1.42	1.42	2.14
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	74.28	5.27	1.32	1.32	1.76	0.44
tenocyte, donor1	11763-123H8	82.74	5.24	2.09	0.00	0.35	3.14
tenocyte, donor2	11765-123I1	77.06	4.96	0.76	0.38	1.53	1.53
tenocyte, donor3	11768-123I4	67.46	3.34	2.22	1.11	0.00	1.85
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	76.65	3.40	1.19	0.85	0.68	1.19
teratocarcinoma cell line:NCR-G1	10798-110I6	93.11	7.71	1.85	1.23	1.23	2.47
teratocarcinoma cell line:PA-1	10807-111A6	50.37	4.65	0.77	0.62	0.31	1.86
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	35.55	5.08	0.63	0.51	0.13	0.89
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	40.09	3.03	0.76	2.65	0.00	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	71.98	8.40	1.42	0.76	0.22	2.07
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	55.70	5.86	0.00	0.33	3.58	0.98
testis, adult, pool1	10026-101D8	76.02	8.05	1.93	4.51	0.43	1.83
testis, adult, pool2	10096-102C6	66.76	4.51	1.80	10.83	0.90	3.61
thalamus - adult, donor10196	10168-103B6	76.18	2.21	0.00	0.00	0.00	3.31
thalamus, adult, donor10252	10154-103A1	113.77	3.59	1.09	0.94	1.09	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	64.66	0.00	0.00	0.00	0.00	3.08
thalamus, adult, donor10258, tech_rep2	10370-105G1	27.83	1.98	0.99	0.16	0.33	0.33
thalamus, newborn, donor10223	10366-105F6	32.22	2.88	1.15	2.30	0.58	1.73
throat, adult	10209-103G2	78.15	10.99	3.99	0.75	2.25	1.50
throat, fetal, donor1	10061-101H7	73.74	13.41	4.27	0.61	1.52	3.66
thymic carcinoma cell line:Ty-82	10803-111A2	25.04	8.55	0.99	0.00	0.20	2.58
thymus, adult, pool1	10027-101D9	100.11	8.45	1.99	1.09	0.50	1.19
thymus, fetal, pool1	10043-101F7	110.45	7.17	1.35	1.77	0.62	0.62
thyroid carcinoma cell line:KHM-5M	10776-110G2	81.64	5.05	1.60	0.93	0.66	1.33
thyroid carcinoma cell line:TCO-1	10783-110G9	95.27	6.84	1.68	1.68	0.14	0.98
thyroid, adult, pool1	10028-101E1	130.64	15.40	3.55	1.59	0.65	2.52
thyroid, fetal, donor1	10060-101H6	58.53	7.12	1.85	0.79	0.26	1.85
tongue epidermis (fungiform papillae), donor1	10288-104F9	126.26	27.72	9.24	0.00	0.00	6.16
tongue, adult	10203-103F5	63.73	12.09	5.35	0.47	0.93	4.42
tongue, fetal, donor1	10059-101H5	68.57	10.64	4.34	0.79	2.76	2.76
tonsil, adult, pool1	10047-101G2	99.27	16.43	5.71	0.60	0.30	5.71
trachea, adult, pool1	10029-101E2	117.87	16.11	4.66	1.23	0.33	3.03
trachea, fetal, donor1	10058-101H4	66.94	12.69	3.46	0.38	0.77	2.31
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	49.95	4.25	1.06	1.06	0.00	1.42
transitional-cell carcinoma cell line:5637	10418-106C4	99.09	12.06	3.14	1.82	0.10	2.74
transitional-cell carcinoma cell line:JMSU1	10492-107B6	62.52	2.51	0.16	0.78	0.31	0.47
tridermal teratoma cell line:HGRT	10694-109G1	173.13	7.61	1.90	1.90	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	105.14	13.97	5.93	1.19	0.68	2.54
umbilical cord, fetal, donor1	10057-101H3	104.33	14.61	0.00	2.09	2.09	0.00
uterus, adult, pool1	10100-102D1	123.71	13.31	3.58	1.19	0.34	3.07
uterus, fetal, donor1	10055-101H1	73.72	11.26	5.12	0.00	3.07	2.05
vagina, adult	10204-103F6	118.25	1.29	0.65	1.94	1.29	0.65
vein, adult	10191-103E2	62.03	4.60	1.75	0.66	1.10	1.75
xeroderma pigentosum b cell line:XPL 17	10563-108A5	78.78	2.40	0.27	1.07	1.87	0.27